Background	Background	NN	0
The	The	DT	0
early	early	JJ	0
diagnosis	diagnosis	NN	0
of	of	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
has	has	VBZ	0
the	the	DT	0
potential	potential	JJ	0
to	to	TO	0
dramatically	dramatically	RB	0
reduce	reduce	VB	0
the	the	DT	0
mortality	mortality	NN	0
associated	associated	VBN	0
with	with	IN	0
this	this	DT	0
disease	disease	NN	0
.	.	.	0
Recently	Recently	RB	0
,	,	,	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
surface-enhanced	surface-enhanced	NN	B-NP
laser	laser	NN	I-NP
desorption	desorption	NN	I-NP
/	/	NN	I-NP
ionization	ionization	NN	I-NP
(	(	-LRB-	0
SELDI	SELDI	NNP	B-NP
)	)	-RRB-	0
time-of-flight	time-of-flight	JJ	B-NP
mass	mass	NN	I-NP
spectrometry	spectrometry	NN	I-NP
profiling	profiling	NN	I-NP
of	of	IN	0
patient	patient	JJ	0
serum	serum	JJ	0
proteins	proteins	NNS	0
,	,	,	0
combined	combined	VBN	0
with	with	IN	0
advanced	advanced	JJ	0
data	data	NN	B-NP
mining	mining	NN	I-NP
algorithm	algorithm	NN	I-NP
,	,	,	0
to	to	TO	0
detect	detect	VB	0
protein	protein	NN	B-NP
pattern	pattern	NN	I-NP
associated	associated	VBN	0
with	with	IN	0
malignancy	malignancy	NN	B-NP
,	,	,	0
has	has	VBZ	0
been	been	VBN	0
reported	reported	VBN	0
as	as	IN	0
a	a	DT	0
promising	promising	JJ	0
field	field	NN	0
of	of	IN	0
research	research	NN	0
to	to	TO	0
achieve	achieve	VB	0
the	the	DT	0
goal	goal	NN	0
of	of	IN	0
early	early	JJ	0
cancer	cancer	NN	B-NP
detection	detection	NN	I-NP
[	[	-LRB-	0
1	1	CD	0
2	2	CD	0
3	3	CD	0
4	4	CD	0
5	5	CD	0
]	]	-RRB-	0
.	.	.	0
Several	Several	JJ	0
reports	reports	NNS	0
have	have	VBP	0
detailed	detailed	VBN	0
the	the	DT	0
ability	ability	NN	B-NP
of	of	IN	0
this	this	DT	0
proteomic	proteomic	JJ	B-NP
method	method	NN	I-NP
to	to	TO	0
diagnose	diagnose	VB	0
the	the	DT	0
difference	difference	NN	0
between	between	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
[	[	-LRB-	0
6	6	CD	0
7	7	CD	0
8	8	CD	0
]	]	-RRB-	0
,	,	,	0
prostate	prostate	JJ	B-NP
cancer	cancer	NN	I-NP
[	[	-LRB-	0
9	9	CD	0
10	10	CD	0
11	11	CD	0
12	12	CD	0
13	13	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
bladder	bladder	JJ	0
cancer	cancer	NN	0
[	[	-LRB-	0
13	13	CD	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
Much	Much	RB	0
of	of	IN	0
the	the	DT	0
effort	effort	NN	0
in	in	IN	0
these	these	DT	0
analyses	analyses	NN	0
has	has	VBZ	0
focused	focused	VBN	0
on	on	IN	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
a	a	DT	0
variety	variety	NN	0
of	of	IN	0
data	data	NN	0
mining	mining	NN	0
tools	tools	NNS	0
such	such	JJ	0
as	as	IN	0
the	the	DT	0
evaluation	evaluation	NN	0
of	of	IN	0
prostate	prostate	JJ	B-NP
cancer	cancer	NN	I-NP
using	using	VBG	0
peaks	peaks	NNS	0
in	in	IN	0
the	the	DT	0
mass	mass	NN	0
to	to	TO	0
charge	charge	VB	0
(	(	-LRB-	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
)	)	-RRB-	0
region	region	NN	0
between	between	IN	0
2	2	CD	0
K	K	NNP	0
and	and	CC	0
40	40	CD	0
K	K	NN	0
combined	combined	VBN	0
with	with	IN	0
boosted	boosted	JJ	0
decision	decision	NN	B-NP
tree	tree	NN	I-NP
analysis	analysis	NN	I-NP
[	[	-LRB-	0
10	10	CD	0
]	]	-RRB-	0
to	to	TO	0
try	try	VB	0
to	to	TO	0
detect	detect	VB	0
patterns	patterns	NNS	0
that	that	WDT	0
allow	allow	VBP	0
the	the	DT	0
diagnosis	diagnosis	NN	0
of	of	IN	0
cancer	cancer	NN	0
versus	versus	IN	0
non-cancer	non-cancer	JJ	B-NP
.	.	.	0
The	The	DT	0
use	use	NN	0
of	of	IN	0
similar	similar	JJ	0
technology	technology	NN	0
to	to	TO	0
evaluate	evaluate	VB	0
bladder	bladder	JJ	0
cancer	cancer	NN	0
has	has	VBZ	0
also	also	RB	0
been	been	VBN	0
reported	reported	VBN	0
[	[	-LRB-	0
13	13	CD	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
this	this	DT	0
field	field	NN	0
represents	represents	VBZ	0
an	an	DT	0
active	active	JJ	0
area	area	NN	0
of	of	IN	0
current	current	JJ	0
research	research	NN	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
a	a	DT	0
recent	recent	JJ	0
report	report	NN	0
by	by	IN	0
the	the	DT	0
Clinical	Clinical	NNP	B-NP
Proteomics	Proteomics	NNP	I-NP
Program	Program	NNP	I-NP
Databank	Databank	NNP	I-NP
has	has	VBZ	0
demonstrated	demonstrated	VBN	0
that	that	IN	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
genetic	genetic	JJ	B-NP
algorithm	algorithm	NN	I-NP
coupled	coupled	VBN	0
with	with	IN	0
clustering	clustering	JJ	0
analysis	analysis	NN	0
has	has	VBZ	0
resulted	resulted	VBN	0
in	in	IN	0
rule	rule	NN	B-NP
set	set	NN	I-NP
that	that	WDT	0
can	can	MD	0
predict	predict	VB	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
(	(	-LRB-	0
including	including	VBG	B-NP
sample	sample	NN	I-NP
from	from	IN	0
patients	patients	NNS	0
with	with	IN	0
stage	stage	NN	0
1	1	CD	0
disease	disease	NN	0
)	)	-RRB-	0
with	with	IN	0
100	100	CD	0
%	%	NN	0
sensitivity	sensitivity	NN	0
and	and	CC	0
96	96	CD	0
%	%	NN	0
specificity	specificity	NNS	0
[	[	-LRB-	0
6	6	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
have	have	VBP	0
been	been	VBN	0
extended	extended	VBN	0
by	by	IN	0
the	the	DT	0
same	same	JJ	0
group	group	NN	0
to	to	TO	0
include	include	VB	0
a	a	DT	0
larger	larger	JJR	0
series	series	NN	0
of	of	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
patient	patient	JJ	I-NP
as	as	IN	0
well	well	RB	0
as	as	IN	0
prostate	prostate	JJ	B-NP
cancer	cancer	NN	I-NP
patient	patient	JJ	I-NP
[	[	-LRB-	0
7	7	CD	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
Clinical	Clinical	NNP	B-NP
Proteomics	Proteomics	NNP	I-NP
Program	Program	NNP	I-NP
Databank	Databank	NNP	I-NP
has	has	VBZ	0
provided	provided	VBN	0
three	three	CD	0
sets	sets	NNS	0
of	of	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
data	data	NN	I-NP
to	to	TO	0
the	the	DT	0
scientific	scientific	JJ	B-NP
community	community	NN	I-NP
without	without	IN	0
restriction	restriction	NN	0
.	.	.	0
These	These	DT	0
data	data	NN	0
sets	sets	NNS	0
include	include	VBP	0
Lancet	Lancet	NNP	B-NP
Ovarian	Ovarian	NNP	I-NP
Data	Data	NNP	I-NP
2-16-02	2-16-02	NNP	0
used	used	VBD	0
in	in	IN	0
the	the	DT	0
study	study	NN	0
noted	noted	VBD	0
above	above	IN	0
[	[	-LRB-	0
6	6	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
study	study	NN	0
consisted	consisted	VBD	0
of	of	IN	0
a	a	DT	0
total	total	NN	0
of	of	IN	0
100	100	CD	0
control	control	NN	0
,	,	,	0
100	100	CD	0
cancer	cancer	NN	0
,	,	,	0
and	and	CC	0
16	16	CD	0
benign	benign	JJ	0
disease	disease	NN	B-NP
sample	sample	NN	I-NP
run	run	VBN	0
on	on	IN	0
a	a	DT	0
Ciphergen	Ciphergen	NNP	B-NP
H4	H4	NNP	I-NP
ProteinChip	ProteinChip	JJ	I-NP
array	array	NN	I-NP
(	(	-LRB-	0
since	since	IN	0
discontinued	discontinued	JJ	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
samples	samples	NNS	0
were	were	VBD	0
manually	manually	RB	0
processed	processed	VBN	0
.	.	.	0
The	The	DT	0
data	data	NNS	0
was	was	VBD	0
posted	posted	VBN	0
after	after	IN	0
baseline	baseline	JJ	B-NP
subtraction	subtraction	NN	I-NP
.	.	.	0
The	The	DT	0
second	second	JJ	0
data	data	NNS	0
set	set	VBN	0
,	,	,	0
Ovarian	Ovarian	NNP	B-NP
Dataset	Dataset	NNP	I-NP
4-3-02	4-3-02	NNP	0
consist	consist	VBP	0
of	of	IN	0
the	the	DT	0
same	same	JJ	0
samples	samples	NNS	0
as	as	IN	0
the	the	DT	0
first	first	JJ	0
but	but	CC	0
the	the	DT	0
samples	samples	NNS	0
were	were	VBD	0
run	run	VBN	0
on	on	IN	0
a	a	DT	0
Ciphergen	Ciphergen	NNP	B-NP
WCX2	WCX2	NNP	I-NP
ProteinChip	ProteinChip	JJ	I-NP
array	array	NN	I-NP
.	.	.	0
The	The	DT	0
samples	samples	NNS	0
were	were	VBD	0
manually	manually	RB	0
prepared	prepared	VBN	0
and	and	CC	0
the	the	DT	0
data	data	NNS	0
was	was	VBD	0
posted	posted	VBN	0
with	with	IN	0
baseline	baseline	JJ	B-NP
subtraction	subtraction	NN	I-NP
.	.	.	0
A	A	DT	0
model	model	NN	0
diagnostic	diagnostic	JJ	B-NP
rule	rule	NN	I-NP
based	based	VBN	0
on	on	IN	0
this	this	DT	0
dataset	dataset	NN	B-NP
is	is	VBZ	0
published	published	VBN	0
on	on	IN	0
the	the	DT	0
website	website	NN	B-NP
,	,	,	0
but	but	CC	0
no	no	DT	0
data	data	NN	0
is	is	VBZ	0
given	given	VBN	0
regarding	regarding	VBG	0
the	the	DT	0
rules	rules	NNS	0
sensitivity	sensitivity	NN	0
or	or	CC	0
specificity	specificity	NN	0
.	.	.	0
In	In	IN	0
this	this	DT	0
report	report	NN	0
,	,	,	0
we	we	PRP	0
analyze	analyze	VBP	0
the	the	DT	0
third	third	JJ	0
Ovarian	Ovarian	NNP	B-NP
Dataset	Dataset	NNP	I-NP
8-7-02	8-7-02	NNP	0
and	and	CC	0
corresponding	corresponding	JJ	0
sample	sample	NN	0
information	information	NN	0
downloaded	downloaded	NN	0
from	from	IN	0
the	the	DT	0
Clinical	Clinical	NNP	B-NP
Proteomics	Proteomics	NNP	I-NP
Program	Program	NNP	I-NP
Databank	Databank	NNP	I-NP
websita	websita	NN	I-NP
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
set	set	NN	0
of	of	IN	0
data	data	NN	0
consists	consists	VBZ	0
of	of	IN	0
serum	serum	JJ	B-NP
profile	profile	NN	I-NP
of	of	IN	0
162	162	CD	0
subject	subject	JJ	B-NP
with	with	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
and	and	CC	0
91	91	CD	0
non-cancer	non-cancer	JJ	B-NP
control	control	NN	I-NP
subject	subject	JJ	I-NP
.	.	.	0
The	The	DT	0
cancer	cancer	NN	B-NP
group	group	NN	I-NP
may	may	MD	0
be	be	VB	0
further	further	RB	0
divided	divided	VBN	0
into	into	IN	0
28	28	CD	0
stage	stage	NN	0
1	1	CD	0
patients	patients	NNS	0
,	,	,	0
20	20	CD	0
stage	stage	NN	0
2	2	CD	0
patients	patients	NNS	0
,	,	,	0
99	99	CD	0
stage	stage	NN	0
3	3	CD	0
patients	patients	NNS	0
,	,	,	0
12	12	CD	0
stage	stage	NN	0
4	4	CD	0
patients	patients	NNS	0
,	,	,	0
and	and	CC	0
3	3	CD	0
no	no	DT	0
stage	stage	NN	0
specified	specified	VBN	0
patients	patients	NNS	0
.	.	.	0
For	For	IN	0
each	each	DT	0
subject	subject	NN	B-NP
a	a	DT	0
set	set	NN	0
of	of	IN	0
data	data	NNS	0
consisting	consisting	VBG	0
of	of	IN	0
intensities	intensities	NN	0
at	at	IN	0
15,154	15,154	CD	0
distinct	distinct	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
ranging	ranging	VBG	0
from	from	IN	0
0.0000786	0.0000786	CD	0
to	to	TO	0
19995.513	19995.513	NNP	0
was	was	VBD	0
available	available	JJ	0
for	for	IN	0
analysis	analysis	NN	0
.	.	.	0
This	This	DT	0
dataset	dataset	NN	B-NP
was	was	VBD	0
constructed	constructed	VBN	0
using	using	VBG	0
the	the	DT	0
Ciphergen	Ciphergen	NNP	B-NP
WCX2	WCX2	NNP	I-NP
ProteinChip	ProteinChip	JJ	I-NP
array	array	NN	I-NP
.	.	.	0
All	All	PDT	0
the	the	DT	0
steps	steps	NNS	0
of	of	IN	0
preparing	preparing	VBG	0
the	the	DT	0
chips	chips	NNS	0
for	for	IN	0
sample	sample	NN	0
analysis	analysis	NN	0
were	were	VBD	0
preformed	preformed	JJ	0
robotically	robotically	NN	0
,	,	,	0
and	and	CC	0
the	the	DT	0
raw	raw	JJ	0
data	data	NNS	0
without	without	IN	0
baseline	baseline	JJ	B-NP
subtraction	subtraction	NN	I-NP
was	was	VBD	0
posted	posted	VBN	0
for	for	IN	0
download	download	NN	B-NP
.	.	.	0
A	A	DT	0
model	model	NN	B-NP
rule	rule	NN	I-NP
claiming	claiming	VBG	0
100	100	CD	0
%	%	NN	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NN	0
is	is	VBZ	0
also	also	RB	0
given	given	VBN	0
.	.	.	0
experimental	experimental	JJ	B-NP
data	data	NN	I-NP
collection	collection	NN	I-NP
additional	additional	JJ	I-NP
detail	detail	NN	I-NP
may	may	MD	0
be	be	VB	0
found	found	VBN	0
at	at	IN	0
the	the	DT	0
Clinical	Clinical	NNP	B-NP
Proteomics	Proteomics	NNP	I-NP
Data	Data	NNP	I-NP
Bank	Bank	NNP	I-NP
[	[	-LRB-	0
5	5	LS	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
the	the	DT	0
various	various	JJ	0
methods	methods	NNS	0
of	of	IN	0
preparing	preparing	VBG	0
and	and	CC	0
running	running	VBG	0
the	the	DT	0
samples	samples	NNS	0
on	on	IN	0
the	the	DT	0
mass	mass	JJ	B-NP
spectrometer	spectrometer	NN	I-NP
,	,	,	0
the	the	DT	0
optimal	optimal	JJ	B-NP
step	step	NN	I-NP
in	in	IN	0
processing	processing	VBG	0
the	the	DT	0
raw	raw	JJ	0
data	data	NNS	0
from	from	IN	0
the	the	DT	0
mass	mass	JJ	B-NP
spectrometer	spectrometer	NN	I-NP
for	for	IN	0
further	further	JJ	0
analysis	analysis	NN	0
have	have	VBP	0
not	not	RB	0
been	been	VBN	0
standardized	standardized	JJ	0
and	and	CC	0
remain	remain	VB	0
a	a	DT	0
fertile	fertile	JJ	0
area	area	NN	0
for	for	IN	0
investigation	investigation	NN	B-NP
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
choose	choose	VBP	0
the	the	DT	0
deliberately	deliberately	RB	0
simple	simple	JJ	0
strategy	strategy	NN	0
of	of	IN	0
using	using	VBG	0
Wilcoxon	Wilcoxon	JJ	B-NP
test	test	NN	I-NP
on	on	IN	0
the	the	DT	0
raw	raw	JJ	0
data	data	NNS	0
to	to	TO	0
better	better	RB	0
understand	understand	VB	0
the	the	DT	0
underlying	underlying	JJ	0
properties	properties	NNS	0
of	of	IN	0
the	the	DT	0
data	data	NNS	0
set	set	VBN	0
.	.	.	0
We	We	PRP	0
consider	consider	VBP	0
this	this	DT	0
simple	simple	JJ	0
approach	approach	NN	0
a	a	DT	0
"benchmark	"benchmark	JJ	0
method	method	NN	0
"	"	''	0
to	to	TO	0
which	which	WDT	0
other	other	JJ	0
methods	methods	NNS	0
can	can	MD	0
be	be	VB	0
compared	compared	VBN	0
.	.	.	0
Further	Further	RB	0
,	,	,	0
we	we	PRP	0
use	use	VBP	0
Wilcoxon	Wilcoxon	JJ	B-NP
test	test	NN	I-NP
and	and	CC	0
stepwise	stepwise	JJ	B-NP
discriminant	discriminant	JJ	I-NP
analysis	analysis	NN	I-NP
on	on	IN	0
a	a	DT	0
training	training	NN	0
subset	subset	VBZ	0
consisting	consisting	VBG	0
of	of	IN	0
80	80	CD	0
cancer	cancer	NN	B-NP
patient	patient	JJ	I-NP
and	and	CC	0
45	45	CD	0
controls	controls	NNS	0
,	,	,	0
randomly	randomly	RB	0
chosen	chosen	VBN	0
from	from	IN	0
the	the	DT	0
original	original	JJ	B-NP
data	data	NN	I-NP
set	set	VBN	0
,	,	,	0
to	to	TO	0
develop	develop	VB	0
rules	rules	NNS	0
to	to	TO	0
classify	classify	VB	0
a	a	DT	0
test	test	NN	0
set	set	VBD	0
consisting	consisting	VBG	0
of	of	IN	0
the	the	DT	0
remaining	remaining	JJ	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	B-NP
subject	subject	JJ	I-NP
.	.	.	0
disease	disease	NN	B-NP
classifier	classifier	NN	I-NP
of	of	IN	0
great	great	JJ	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NN	0
could	could	MD	0
be	be	VB	0
readily	readily	RB	0
constructed	constructed	VBN	0
by	by	IN	0
visual	visual	JJ	0
inspection	inspection	NN	0
and	and	CC	0
m/z	m/z	NN	B-NP
manual	manual	JJ	I-NP
binning	binning	NN	I-NP
values	values	VBZ	0
based	based	VBN	0
on	on	IN	0
the	the	DT	0
wilcoxon	wilcoxon	NNP	B-NP
test	test	NN	I-NP
p-value	p-value	NN	I-NP
combined	combined	VBN	0
with	with	IN	0
classical	classical	JJ	B-NP
stepwise	stepwise	JJ	I-NP
discriminant	discriminant	JJ	I-NP
analysis	analysis	NN	I-NP
.	.	.	0
The	The	DT	0
ability	ability	NN	B-NP
of	of	IN	0
these	these	DT	0
rules	rules	NNS	0
to	to	TO	0
classify	classify	VB	0
disease	disease	NN	0
and	and	CC	0
normal	normal	JJ	B-NP
sample	sample	NN	I-NP
were	were	VBD	0
comparable	comparable	JJ	0
to	to	TO	0
the	the	DT	0
model	model	NN	B-NP
rule	rule	NN	I-NP
published	published	VBN	0
on	on	IN	0
this	this	DT	0
dataset	dataset	NN	B-NP
at	at	IN	0
the	the	DT	0
Clinical	Clinical	NNP	B-NP
Proteomics	Proteomics	NNP	I-NP
Program	Program	NNP	I-NP
Databank	Databank	NNP	I-NP
website	website	NN	I-NP
which	which	WDT	0
was	was	VBD	0
developed	developed	VBN	0
using	using	VBG	0
a	a	DT	0
proprietary	proprietary	JJ	B-NP
genetic	genetic	JJ	I-NP
algorithm	algorithm	NN	I-NP
.	.	.	0
Further	Further	RB	0
,	,	,	0
in	in	IN	0
examining	examining	VBG	0
all	all	DT	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
,	,	,	0
the	the	DT	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
that	that	WDT	0
discriminated	discriminated	VBP	0
best	best	RB	0
between	between	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
and	and	CC	0
control	control	NN	0
were	were	VBD	0
all	all	DT	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
less	less	JJR	0
than	than	IN	0
500	500	CD	0
,	,	,	0
an	an	DT	0
area	area	NN	0
of	of	IN	0
the	the	DT	0
spectrum	spectrum	NN	B-NP
often	often	RB	0
discarded	discarded	VBN	0
as	as	IN	0
noise	noise	NN	0
[	[	-LRB-	0
10	10	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
findings	findings	NNS	0
are	are	VBP	0
useful	useful	JJ	0
for	for	IN	0
several	several	JJ	0
reasons	reasons	NNS	0
.	.	.	0
First	First	NNP	0
,	,	,	0
the	the	DT	0
statistical	statistical	JJ	B-NP
method	method	NN	I-NP
used	used	VBN	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
are	are	VBP	0
readily	readily	RB	0
available	available	JJ	0
,	,	,	0
widely	widely	RB	0
understood	understood	VBN	0
,	,	,	0
and	and	CC	0
can	can	MD	0
be	be	VB	0
cheaply	cheaply	RB	0
implemented	implemented	VBN	0
.	.	.	0
Secondly	Secondly	RB	0
,	,	,	0
a	a	DT	0
vast	vast	JJ	0
amount	amount	NN	0
of	of	IN	0
mathematical	mathematical	JJ	B-NP
research	research	NN	I-NP
and	and	CC	0
practical	practical	JJ	B-NP
experience	experience	NN	I-NP
underlies	underlies	VBD	0
their	their	PRP$	0
interpretation	interpretation	NN	B-NP
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
they	they	PRP	0
can	can	MD	0
be	be	VB	0
used	used	VBN	0
to	to	TO	0
discover	discover	VB	0
unexpected	unexpected	JJ	0
patterns	patterns	NNS	0
present	present	JJ	0
in	in	IN	0
the	the	DT	0
data	data	NNS	0
set	set	VBN	0
.	.	.	0
These	These	DT	0
patterns	patterns	NNS	0
may	may	MD	0
be	be	VB	0
missed	missed	VBN	0
by	by	IN	0
machine	machine	NN	0
learning	learning	VBG	B-NP
method	method	NN	I-NP
that	that	WDT	0
are	are	VBP	0
narrowly	narrowly	RB	0
focused	focused	VBN	0
on	on	IN	0
diagnostic	diagnostic	JJ	B-NP
classification	classification	NN	I-NP
,	,	,	0
and	and	CC	0
do	do	VBP	0
not	not	RB	0
present	present	VB	0
the	the	DT	0
researcher	researcher	NN	0
with	with	IN	0
a	a	DT	0
broad	broad	JJ	0
overview	overview	NN	B-NP
of	of	IN	0
the	the	DT	0
data	data	NNS	0
.	.	.	0
As	As	IN	0
a	a	DT	0
result	result	NN	0
of	of	IN	0
these	these	DT	0
traditional	traditional	JJ	0
studies	studies	NNS	0
,	,	,	0
a	a	DT	0
better	better	JJR	0
understanding	understanding	NN	0
of	of	IN	0
the	the	DT	0
weaknesses	weaknesses	NNS	0
and	and	CC	0
possible	possible	JJ	0
strengths	strengths	NNS	0
of	of	IN	0
proteomic	proteomic	JJ	B-NP
profiling	profiling	NN	I-NP
serum	serum	JJ	I-NP
becomes	becomes	VBZ	0
apparent	apparent	JJ	0
.	.	.	0
Results	Results	NNS	0
and	and	CC	0
Discussion	Discussion	NNP	0
Based	Based	NNP	0
on	on	IN	0
the	the	DT	0
initial	initial	JJ	0
training	training	NN	B-NP
set	set	NN	I-NP
,	,	,	0
the	the	DT	0
intensity	intensity	NN	0
at	at	IN	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
consecutive	consecutive	JJ	0
15,154	15,154	NNP	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
was	was	VBD	0
first	first	RB	0
compared	compared	VBN	0
using	using	VBG	0
a	a	DT	0
two-sided	two-sided	JJ	0
Wilcoxon	Wilcoxon	JJ	B-NP
test	test	NN	I-NP
(	(	-LRB-	0
see	see	VB	0
methods	methods	NNS	0
)	)	-RRB-	0
Figure	Figure	NN	0
1shows	1shows	VBZ	0
the	the	DT	0
pattern	pattern	NN	0
of	of	IN	0
the	the	DT	0
resulting	resulting	VBG	0
two-sided	two-sided	JJ	0
wilcoxon	wilcoxon	NNP	B-NP
test	test	NN	I-NP
p-value	p-value	NN	I-NP
generated	generated	VBD	0
on	on	IN	0
a	a	DT	0
training	training	NN	0
set	set	VBD	0
consisting	consisting	VBG	0
of	of	IN	0
80	80	CD	0
cancer	cancer	NN	B-NP
patient	patient	JJ	I-NP
and	and	CC	0
45	45	CD	0
controls	controls	NNS	0
randomly	randomly	RB	0
chosen	chosen	VBN	0
from	from	IN	0
the	the	DT	0
larger	larger	JJR	0
data	data	NNS	0
set	set	VBN	0
,	,	,	0
with	with	IN	0
the	the	DT	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
on	on	IN	0
the	the	DT	0
x-axis	x-axis	JJ	B-NP
and	and	CC	0
the	the	DT	0
negative	negative	JJ	B-NP
logarithm	logarithm	NN	I-NP
(	(	-LRB-	0
base	base	NN	0
10	10	CD	0
)	)	-RRB-	0
of	of	IN	0
the	the	DT	0
wilcoxon	wilcoxon	NNP	B-NP
test	test	NN	I-NP
p-value	p-value	NN	I-NP
on	on	IN	0
the	the	DT	0
y-axis	y-axis	JJ	B-NP
.	.	.	0
There	There	EX	0
are	are	VBP	0
a	a	DT	0
total	total	NN	0
of	of	IN	0
685	685	CD	0
distinct	distinct	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
differing	differing	VBG	0
between	between	IN	0
the	the	DT	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	B-NP
population	population	NN	I-NP
with	with	IN	0
a	a	DT	0
p-value	p-value	JJ	B-NP
of	of	IN	0
less	less	JJR	0
than	than	IN	0
10	10	CD	0
-6	-6	CD	0
.	.	.	0
Also	Also	RB	0
of	of	IN	0
note	note	NN	0
in	in	IN	0
this	this	DT	0
distribution	distribution	NN	B-NP
is	is	VBZ	0
that	that	IN	0
all	all	DT	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
with	with	IN	0
a	a	DT	0
Wilcoxon	Wilcoxon	NNP	B-NP
p-value	p-value	NNP	I-NP
less	less	RBR	0
than	than	IN	0
10	10	CD	0
-12are	-12are	CD	0
found	found	VBN	0
at	at	IN	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
less	less	JJR	0
than	than	IN	0
500	500	CD	0
.	.	.	0
The	The	DT	0
significance	significance	NN	B-NP
of	of	IN	0
this	this	DT	0
finding	finding	NN	0
will	will	MD	0
be	be	VB	0
discussed	discussed	VBN	0
further	further	RBR	0
below	below	RB	0
.	.	.	0
In	In	IN	0
order	order	NN	0
to	to	TO	0
determine	determine	VB	0
if	if	IN	0
these	these	DT	0
data	data	NNS	0
could	could	MD	0
be	be	VB	0
used	used	VBN	0
to	to	TO	0
separate	separate	VB	0
normal	normal	JJ	0
from	from	IN	0
cancer	cancer	NN	0
,	,	,	0
we	we	PRP	0
used	used	VBD	0
three	three	CD	0
strategies	strategies	NNS	0
to	to	TO	0
develop	develop	VB	0
rules	rules	NNS	0
for	for	IN	0
diagnostic	diagnostic	JJ	B-NP
classification	classification	NN	I-NP
.	.	.	0
First	First	NNP	0
,	,	,	0
all	all	DT	0
data	data	NN	0
points	points	NNS	0
regardless	regardless	RB	0
of	of	IN	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
value	value	NN	I-NP
were	were	VBD	0
sorted	sorted	VBN	0
from	from	IN	0
most	most	JJS	0
to	to	TO	0
least	least	JJS	0
significant	significant	JJ	0
(	(	-LRB-	0
according	according	VBG	0
to	to	TO	0
the	the	DT	0
two-sided	two-sided	JJ	0
wilcoxon	wilcoxon	NNP	B-NP
test	test	NN	I-NP
p-value	p-value	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
the	the	DT	0
100	100	CD	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
with	with	IN	0
the	the	DT	0
lowest	lowest	JJS	0
p-value	p-value	NN	B-NP
were	were	VBD	0
chosen	chosen	VBN	0
.	.	.	0
These	These	DT	0
100	100	CD	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
were	were	VBD	0
then	then	RB	0
separated	separated	VBN	0
into	into	IN	0
distinct	distinct	JJ	0
bins	bins	NN	0
by	by	IN	0
sorting	sorting	VBG	0
on	on	IN	0
consecutive	consecutive	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
and	and	CC	0
requiring	requiring	VBG	0
a	a	DT	0
separation	separation	NN	0
of	of	IN	0
at	at	IN	0
least	least	JJS	0
1	1	CD	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
value	value	NN	I-NP
to	to	TO	0
start	start	VB	0
the	the	DT	0
next	next	JJ	0
bin	bin	NNS	0
(	(	-LRB-	0
12	12	CD	0
bins	bins	NNS	0
were	were	VBD	0
detected	detected	VBN	0
in	in	IN	0
this	this	DT	0
process	process	NN	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
value	value	NN	I-NP
with	with	IN	0
the	the	DT	0
smallest	smallest	JJS	0
p-value	p-value	JJ	B-NP
in	in	IN	0
each	each	DT	0
bin	bin	NN	0
was	was	VBD	0
selected	selected	VBN	0
.	.	.	0
The	The	DT	0
results	results	NNS	0
are	are	VBP	0
shown	shown	VBN	0
in	in	IN	0
Table	Table	NNP	0
1	1	CD	0
.	.	.	0
Next	Next	JJ	B-NP
,	,	,	0
stepwise	stepwise	JJ	0
discriminate	discriminate	JJ	0
analysis	analysis	NN	0
was	was	VBD	0
performed	performed	VBN	0
,	,	,	0
and	and	CC	0
7	7	CD	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
were	were	VBD	0
selected	selected	VBN	0
for	for	IN	0
Rule	Rule	NNP	0
1	1	CD	0
(	(	-LRB-	0
of	of	IN	0
note	note	NN	0
,	,	,	0
all	all	DT	0
but	but	CC	0
one	one	CD	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
value	value	NN	I-NP
was	was	VBD	0
below	below	IN	0
500	500	CD	0
)	)	-RRB-	0
.	.	.	0
When	When	WRB	0
this	this	DT	0
rule	rule	NN	0
was	was	VBD	0
applied	applied	VBN	0
to	to	TO	0
the	the	DT	0
entire	entire	JJ	0
data	data	NNS	0
set	set	VBN	0
,	,	,	0
test	test	NN	0
and	and	CC	0
training	training	NN	0
inclusive	inclusive	NN	0
,	,	,	0
all	all	DT	0
162	162	CD	0
cancer	cancer	NN	0
and	and	CC	0
91	91	CD	0
controls	controls	NNS	0
were	were	VBD	0
appropriately	appropriately	RB	0
classified	classified	VBN	0
without	without	IN	0
error	error	NN	0
for	for	IN	0
100	100	CD	0
%	%	NN	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NN	0
.	.	.	0
Given	Given	VBN	0
that	that	IN	0
the	the	DT	0
interpretation	interpretation	NN	B-NP
of	of	IN	0
low	low	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
maybe	maybe	RB	0
problematic	problematic	JJ	0
,	,	,	0
we	we	PRP	0
next	next	RB	0
focused	focused	VBN	B-NP
attention	attention	NN	I-NP
on	on	IN	0
a	a	DT	0
set	set	NN	0
of	of	IN	0
rules	rules	NNS	0
which	which	WDT	0
met	met	VBD	0
the	the	DT	0
following	following	JJ	0
requirement	requirement	NN	B-NP
.	.	.	0
First	First	NNP	0
,	,	,	0
the	the	DT	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
value	value	NN	I-NP
had	had	VBD	0
to	to	TO	0
exceed	exceed	VB	0
2000	2000	CD	0
,	,	,	0
and	and	CC	0
the	the	DT	0
Wilcoxon	Wilcoxon	JJ	B-NP
test	test	NN	I-NP
P-value	P-value	NN	I-NP
had	had	VBD	0
to	to	TO	0
be	be	VB	0
less	less	JJR	0
than	than	IN	0
10	10	CD	0
-6	-6	CD	0
.	.	.	0
A	A	DT	0
total	total	NN	0
of	of	IN	0
462	462	CD	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
from	from	IN	0
the	the	DT	0
training	training	NN	0
set	set	VBD	0
met	met	VBN	0
these	these	DT	0
criteria	criteria	NNS	0
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Table	Table	NNP	0
2	2	CD	0
,	,	,	0
a	a	DT	0
total	total	NN	0
of	of	IN	0
30	30	CD	0
bins	bins	NNS	0
were	were	VBD	0
detected	detected	VBN	0
by	by	IN	0
sorting	sorting	VBG	0
on	on	IN	0
consecutive	consecutive	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
as	as	RB	0
above	above	RB	0
,	,	,	0
and	and	CC	0
the	the	DT	0
most	most	RBS	0
significant	significant	JJ	0
p-value	p-value	NN	B-NP
from	from	IN	0
each	each	DT	0
bin	bin	NN	0
was	was	VBD	0
selected	selected	VBN	0
for	for	IN	0
stepwise	stepwise	JJ	B-NP
discriminant	discriminant	JJ	I-NP
analysis	analysis	NN	I-NP
.	.	.	0
Thirteen	Thirteen	NNP	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
were	were	VBD	0
retained	retained	VBN	0
in	in	IN	0
Rule	Rule	NNP	0
2	2	CD	0
.	.	.	0
In	In	IN	0
the	the	DT	0
training	training	NN	B-NP
set	set	NN	I-NP
,	,	,	0
one	one	CD	0
subject	subject	NN	B-NP
in	in	IN	0
the	the	DT	0
cancer	cancer	NN	B-NP
group	group	NN	I-NP
was	was	VBD	0
misclassified	misclassified	VBN	0
as	as	IN	0
normal	normal	JJ	0
and	and	CC	0
one	one	CD	0
in	in	IN	0
the	the	DT	0
control	control	NN	B-NP
group	group	NN	I-NP
was	was	VBD	0
misclassified	misclassified	VBN	0
as	as	IN	0
cancer	cancer	NN	0
.	.	.	0
In	In	IN	0
the	the	DT	0
test	test	NN	B-NP
set	set	NN	I-NP
,	,	,	0
two	two	CD	0
subject	subject	JJ	B-NP
from	from	IN	0
the	the	DT	0
control	control	NN	B-NP
group	group	NN	I-NP
were	were	VBD	0
misclassified	misclassified	VBN	0
as	as	IN	0
cancer	cancer	NN	0
.	.	.	0
Therefore	Therefore	RB	0
for	for	IN	0
the	the	DT	0
test	test	NN	B-NP
set	set	NN	I-NP
,	,	,	0
the	the	DT	0
sensitivity	sensitivity	NN	0
was	was	VBD	0
82	82	CD	0
/	/	CD	0
82	82	CD	0
or	or	CC	0
100	100	CD	0
%	%	NN	0
and	and	CC	0
the	the	DT	0
specificity	specificity	NN	0
was	was	VBD	0
43	43	CD	0
/	/	CD	0
45	45	CD	0
or	or	CC	0
95.7	95.7	CD	0
%	%	NN	0
.	.	.	0
For	For	IN	0
the	the	DT	0
test	test	NN	0
and	and	CC	0
training	training	NN	0
set	set	VBD	0
combined	combined	VBN	0
,	,	,	0
one	one	CD	0
subject	subject	NN	B-NP
was	was	VBD	0
misclassified	misclassified	VBN	0
in	in	IN	0
the	the	DT	0
cancer	cancer	NN	B-NP
group	group	NN	I-NP
as	as	IN	0
normal	normal	JJ	0
and	and	CC	0
three	three	CD	0
subject	subject	JJ	B-NP
were	were	VBD	0
misclassified	misclassified	VBN	0
in	in	IN	0
the	the	DT	0
control	control	NN	B-NP
group	group	NN	I-NP
as	as	IN	0
cancer	cancer	NN	0
.	.	.	0
Thus	Thus	RB	0
for	for	IN	0
this	this	DT	0
rule	rule	NN	0
the	the	DT	0
overall	overall	JJ	0
sensitivity	sensitivity	NN	0
was	was	VBD	0
161	161	CD	0
/	/	CD	0
162	162	CD	0
or	or	CC	0
99.4	99.4	CD	0
%	%	NN	0
and	and	CC	0
its	its	PRP$	0
overall	overall	JJ	0
specificity	specificity	NN	0
was	was	VBD	0
88	88	CD	0
/	/	CD	0
91	91	CD	0
or	or	CC	0
96.7	96.7	CD	0
%	%	NN	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
Rule	Rule	NNP	0
3	3	CD	0
was	was	VBD	0
constructed	constructed	VBN	0
using	using	VBG	0
the	the	DT	0
30	30	CD	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
in	in	IN	0
Rule	Rule	NNP	0
2	2	CD	0
combined	combined	VBN	0
with	with	IN	0
four	four	CD	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
409.75936	409.75936	NNP	0
,	,	,	0
418.11364	418.11364	NNP	0
,	,	,	0
435.0751	435.0751	NNP	0
,	,	,	0
and	and	CC	0
464.3617	464.3617	NNP	0
(	(	-LRB-	0
all	all	DT	0
also	also	RB	0
used	used	VBN	0
in	in	IN	0
Rule	Rule	NNP	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
was	was	VBD	0
done	done	VBN	0
because	because	IN	0
prior	prior	JJ	0
studies	studies	NNS	0
have	have	VBP	0
indicated	indicated	VBN	0
the	the	DT	0
possible	possible	JJ	0
presence	presence	NN	0
of	of	IN	0
low	low	JJ	0
molecular	molecular	JJ	B-NP
weight	weight	NN	I-NP
biomarker	biomarker	NN	I-NP
in	in	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
(	(	-LRB-	0
see	see	VB	0
below	below	IN	0
)	)	-RRB-	0
.	.	.	0
When	When	WRB	0
this	this	DT	0
set	set	NN	0
of	of	IN	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
was	was	VBD	0
subjected	subjected	VBN	0
to	to	TO	0
stepwise	stepwise	VB	0
discriminant	discriminant	JJ	B-NP
analysis	analysis	NN	I-NP
,	,	,	0
seven	seven	CD	0
variables	variables	NNS	0
at	at	IN	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
418.1136	418.1136	NNP	0
,	,	,	0
435.0751	435.0751	NNP	0
,	,	,	0
464.3617	464.3617	NNP	0
,	,	,	0
4003.645	4003.645	NNP	0
,	,	,	0
4906.962	4906.962	NNP	0
,	,	,	0
6599.8232	6599.8232	NNP	0
,	,	,	0
and	and	CC	0
6801.495	6801.495	NNP	0
were	were	VBD	0
retained	retained	VBN	0
.	.	.	0
When	When	WRB	0
Rule	Rule	NNP	0
3	3	CD	0
was	was	VBD	0
applied	applied	VBN	0
to	to	TO	0
the	the	DT	0
entire	entire	JJ	0
data	data	NNS	0
set	set	VBN	0
,	,	,	0
test	test	NN	0
and	and	CC	0
training	training	NN	0
inclusive	inclusive	NN	0
,	,	,	0
all	all	DT	0
162	162	CD	0
cancer	cancer	NN	0
and	and	CC	0
91	91	CD	0
controls	controls	NNS	0
were	were	VBD	0
appropriately	appropriately	RB	0
categorized	categorized	VBN	0
without	without	IN	0
error	error	NN	0
for	for	IN	0
100	100	CD	0
%	%	NN	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NN	0
.	.	.	0
The	The	DT	0
actual	actual	JJ	0
classification	classification	JJ	B-NP
schema	schema	NN	I-NP
for	for	IN	0
all	all	DT	0
three	three	CD	0
rules	rules	NNS	0
is	is	VBZ	0
shown	shown	VBN	0
in	in	IN	0
Table	Table	NNP	0
3	3	CD	0
.	.	.	0
The	The	DT	0
results	results	NNS	0
presented	presented	VBN	0
with	with	IN	0
these	these	DT	0
three	three	CD	0
rules	rules	NNS	0
were	were	VBD	0
all	all	DT	0
achieved	achieved	VBN	0
in	in	IN	0
the	the	DT	0
first	first	JJ	0
attempt	attempt	NN	0
.	.	.	0
No	No	DT	0
effort	effort	NN	0
was	was	VBD	0
made	made	VBN	0
to	to	TO	0
further	further	VB	0
optimize	optimize	VBN	0
these	these	DT	0
rules	rules	NNS	0
.	.	.	0
We	We	PRP	0
next	next	IN	0
interchanged	interchanged	VBG	0
the	the	DT	0
test	test	NN	0
and	and	CC	0
training	training	NN	B-NP
set	set	NN	I-NP
and	and	CC	0
used	used	VBD	0
the	the	DT	0
same	same	JJ	0
three	three	CD	0
rule	rule	NN	B-NP
development	development	NN	I-NP
strategy	strategy	NN	I-NP
.	.	.	0
This	This	DT	0
resulted	resulted	VBN	0
in	in	IN	0
:	:	:	0
1	1	LS	0
)	)	-RRB-	0
Rule	Rule	NNP	0
1	1	CD	0
with	with	IN	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
2.8234234	2.8234234	NNP	0
,	,	,	0
222.41828	222.41828	NNP	0
,	,	,	0
410.13727	410.13727	NNP	0
,	,	,	0
417.73207	417.73207	NNP	0
,	,	,	0
435.07512	435.07512	NNP	0
,	,	,	0
4027.2999	4027.2999	NNP	0
,	,	,	0
and	and	CC	0
8035.0581	8035.0581	NNP	0
,	,	,	0
achieved	achieved	VBD	0
100	100	CD	0
%	%	NN	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NN	0
on	on	IN	0
both	both	PDT	0
the	the	DT	0
test	test	NN	0
and	and	CC	0
training	training	NN	B-NP
set	set	NN	I-NP
2	2	CD	0
)	)	-RRB-	0
Rule	Rule	NNP	0
2	2	CD	0
with	with	IN	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
3676.3951	3676.3951	NNP	0
,	,	,	0
3937.7816	3937.7816	NNP	0
,	,	,	0
4003.6449	4003.6449	NNP	0
,	,	,	0
4440.095	4440.095	NNP	0
,	,	,	0
5269.0367	5269.0367	NNP	0
,	,	,	0
10511.699	10511.699	NNP	0
,	,	,	0
14182.82	14182.82	NNP	0
,	,	,	0
and	and	CC	0
17019.433	17019.433	NNP	0
.	.	.	0
This	This	DT	0
rule	rule	NN	0
achieved	achieved	VBD	0
100	100	CD	0
%	%	NN	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NN	0
on	on	IN	0
the	the	DT	0
training	training	NN	B-NP
set	set	NN	I-NP
.	.	.	0
However	However	RB	0
sensitivity	sensitivity	JJ	0
and	and	CC	0
specificity	specificity	NN	0
fell	fell	VBD	0
on	on	IN	0
the	the	DT	0
test	test	NN	0
set	set	VBN	0
to	to	TO	0
96.25	96.25	CD	0
%	%	NN	0
and	and	CC	0
91.11	91.11	CD	0
%	%	NN	0
respectively.	respectively.	CD	0
3	3	CD	0
)	)	-RRB-	0
Rule	Rule	NNP	0
3	3	CD	0
with	with	IN	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
417.73207	417.73207	NNP	0
,	,	,	0
435.07512	435.07512	NNP	0
,	,	,	0
2666.361	2666.361	NNP	0
,	,	,	0
2674.0769	2674.0769	NNP	0
,	,	,	0
3937.7816	3937.7816	NNP	0
,	,	,	0
3991.8435	3991.8435	NNP	0
,	,	,	0
4821.0481	4821.0481	NNP	0
,	,	,	0
4839.2088	4839.2088	NNP	0
,	,	,	0
5269.0367	5269.0367	NNP	0
,	,	,	0
7627.1183	7627.1183	NNP	0
,	,	,	0
14182.82	14182.82	NNP	0
,	,	,	0
and	and	CC	0
17019.433	17019.433	NNP	0
.	.	.	0
This	This	DT	0
rule	rule	NN	0
achieved	achieved	VBD	0
100	100	CD	0
%	%	NN	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NN	0
on	on	IN	0
the	the	DT	0
training	training	NN	B-NP
set	set	NN	I-NP
.	.	.	0
On	On	IN	0
the	the	DT	0
test	test	NN	0
set	set	VBD	0
it	it	PRP	0
achieved	achieved	VBD	0
a	a	DT	0
sensitivity	sensitivity	NN	0
of	of	IN	0
100	100	CD	0
%	%	NN	0
and	and	CC	0
a	a	DT	0
specificity	specificity	NN	0
of	of	IN	0
97.8	97.8	CD	0
%	%	NN	0
.	.	.	0
We	We	PRP	0
have	have	VBP	0
used	used	VBN	0
a	a	DT	0
strategy	strategy	NN	0
identical	identical	NN	0
to	to	TO	0
that	that	DT	0
used	used	VBN	0
in	in	IN	0
Rule	Rule	NNP	0
1	1	CD	0
to	to	TO	0
further	further	RB	0
analyze	analyze	VB	0
this	this	DT	0
data	data	NNS	0
.	.	.	0
First	First	NNP	0
,	,	,	0
a	a	DT	0
randomly	randomly	RB	0
cancer	cancer	NN	B-NP
spectrum	spectrum	NN	I-NP
ordered	ordered	VBN	I-NP
list	list	NN	I-NP
and	and	CC	0
a	a	DT	0
randomly	randomly	RB	0
control	control	NN	B-NP
spectrum	spectrum	NN	I-NP
ordered	ordered	VBN	I-NP
list	list	NN	I-NP
were	were	VBD	0
prepared	prepared	VBN	0
.	.	.	0
Next	Next	JJ	B-NP
,	,	,	0
we	we	PRP	0
assigned	assigned	VBD	0
the	the	DT	0
first	first	JJ	0
20	20	CD	0
%	%	NN	0
of	of	IN	0
each	each	DT	0
list	list	NN	0
to	to	TO	0
a	a	DT	0
test	test	NN	B-NP
set	set	NN	I-NP
and	and	CC	0
the	the	DT	0
remaining	remaining	JJ	0
80	80	CD	0
%	%	NN	0
to	to	TO	0
a	a	DT	0
training	training	NN	B-NP
set	set	NN	I-NP
.	.	.	0
The	The	DT	0
process	process	NN	0
was	was	VBD	0
repeated	repeated	VBN	0
five	five	CD	0
times	times	NNS	0
assigning	assigning	VBP	0
the	the	DT	0
next	next	JJ	0
consecutive	consecutive	JJ	0
20	20	CD	0
%	%	NN	0
of	of	IN	0
each	each	DT	0
list	list	NN	0
for	for	IN	0
the	the	DT	0
test	test	NN	0
set	set	VBN	0
on	on	IN	0
each	each	DT	0
occasion	occasion	NN	0
.	.	.	0
The	The	DT	0
results	results	NNS	0
were	were	VBD	0
very	very	RB	0
similar	similar	JJ	0
to	to	TO	0
those	those	DT	0
above	above	JJ	0
with	with	IN	0
all	all	DT	0
five	five	CD	0
rules	rules	NNS	0
achieving	achieving	VBG	0
100	100	CD	0
%	%	NN	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NN	0
.	.	.	0
This	This	DT	0
data	data	NN	0
is	is	VBZ	0
posted	posted	VBN	0
as	as	IN	0
additional	additional	JJ	0
data	data	NNS	0
file	file	VBP	0
Supplement1.xls	Supplement1.xls	CD	B-NP
.	.	.	0
Additional	Additional	JJ	B-NP
File	File	NNP	I-NP
1	1	CD	0
This	This	DT	0
Excel	Excel	NNP	0
file	file	NN	0
contains	contains	VBZ	0
5	5	CD	0
work	work	NN	B-NP
sheet	sheet	NN	I-NP
.	.	.	0
Each	Each	DT	0
sheet	sheet	NN	0
contains	contains	VBZ	0
the	the	DT	0
most	most	RBS	0
significant	significant	JJ	0
100	100	CD	0
mz	mz	NN	B-NP
value	value	NN	I-NP
from	from	IN	0
a	a	DT	0
training	training	NN	0
set	set	VBD	0
consisting	consisting	VBG	0
of	of	IN	0
a	a	DT	0
different	different	JJ	0
80	80	CD	0
%	%	NN	0
subset	subset	NN	B-NP
of	of	IN	0
the	the	DT	0
data	data	NNS	0
.	.	.	0
The	The	DT	0
mz	mz	NN	B-NP
value	value	NN	I-NP
have	have	VBP	0
been	been	VBN	0
sorted	sorted	VBN	0
into	into	IN	0
bins	bins	NN	0
and	and	CC	0
the	the	DT	0
most	most	RBS	0
significant	significant	JJ	0
MZ	MZ	NNP	B-NP
value	value	NN	I-NP
from	from	IN	0
each	each	DT	0
bin	bin	NN	0
(	(	-LRB-	0
marked	marked	VBN	0
with	with	IN	0
a	a	DT	0
"I	"I	NN	0
"	"	''	0
in	in	IN	0
column	column	NN	B-NP
E	E	NN	I-NP
)	)	-RRB-	0
was	was	VBD	0
used	used	VBN	0
in	in	IN	0
stepwise	stepwise	JJ	B-NP
dicriminant	dicriminant	JJ	I-NP
analysis	analysis	NN	I-NP
.	.	.	0
MZ	MZ	NNP	B-NP
values	values	VBZ	0
retained	retained	VBN	0
in	in	IN	0
the	the	DT	0
final	final	JJ	B-NP
rule	rule	NN	I-NP
are	are	VBP	0
indicated	indicated	VBN	0
with	with	IN	0
an	an	DT	0
"s	"s	NN	0
"	"	''	0
in	in	IN	0
column	column	NN	B-NP
F.	F.	NNP	I-NP
Click	Click	NNP	0
here	here	RB	0
for	for	IN	0
file	file	VB	0
The	The	DT	0
presence	presence	NN	0
of	of	IN	0
statistically	statistically	JJ	0
significant	significant	JJ	0
signals	signals	NNS	0
at	at	IN	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
less	less	JJR	0
than	than	IN	0
500	500	CD	0
was	was	VBD	0
unexpected	unexpected	JJ	0
as	as	IN	0
some	some	DT	0
investigator	investigator	NN	B-NP
,	,	,	0
in	in	IN	0
their	their	PRP$	0
systems	systems	NNS	0
,	,	,	0
conservatively	conservatively	RB	0
disregard	disregard	JJ	B-NP
data	data	NN	I-NP
beneath	beneath	IN	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
2000	2000	CD	0
as	as	IN	0
possible	possible	JJ	0
noise	noise	NN	0
[	[	-LRB-	0
12	12	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
further	further	RB	0
investigate	investigate	VB	0
this	this	DT	0
,	,	,	0
we	we	PRP	0
first	first	RB	0
repeated	repeated	VBN	0
the	the	DT	0
calculation	calculation	NN	0
of	of	IN	0
2-sided	2-sided	NNP	0
wilcoxon	wilcoxon	NNP	B-NP
test	test	NN	I-NP
p-value	p-value	NN	I-NP
at	at	IN	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
15,154	15,154	NNP	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
using	using	VBG	0
the	the	DT	0
entire	entire	JJ	0
data	data	NNS	0
set	set	VBN	0
(	(	-LRB-	0
see	see	VB	0
Figure	Figure	NNP	0
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
trends	trends	NNS	0
noted	noted	VBD	0
in	in	IN	0
the	the	DT	0
training	training	NN	B-NP
set	set	NN	I-NP
were	were	VBD	0
present	present	JJ	0
in	in	IN	0
the	the	DT	0
entire	entire	JJ	0
data	data	NNS	0
set	set	VBN	0
,	,	,	0
although	although	IN	0
with	with	IN	0
increased	increased	JJ	0
statistical	statistical	JJ	B-NP
significance	significance	NN	I-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
3,591	3,591	NN	0
of	of	IN	0
the	the	DT	0
15,154	15,154	NNP	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
had	had	VBD	0
mean	mean	JJ	0
intensities	intensities	NN	0
that	that	WDT	0
varied	varied	VBD	0
between	between	IN	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	0
with	with	IN	0
a	a	DT	0
p-value	p-value	JJ	B-NP
of	of	IN	0
10	10	CD	0
-6or	-6or	CD	0
less	less	JJR	0
.	.	.	0
In	In	IN	0
a	a	DT	0
sample	sample	NN	0
of	of	IN	0
a	a	DT	0
panel	panel	NN	0
consisting	consisting	VBG	0
of	of	IN	0
15,154	15,154	CD	0
independent	independent	JJ	0
random	random	JJ	0
sets	sets	NNS	0
of	of	IN	0
measurements	measurements	JJ	B-NP
split	split	NN	I-NP
between	between	IN	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	0
,	,	,	0
using	using	VBG	0
Wilcoxon	Wilcoxon	JJ	B-NP
test	test	NN	I-NP
15,154	15,154	CD	0
times	times	NNS	0
with	with	IN	0
an	an	DT	0
individual	individual	JJ	B-NP
significance	significance	NN	I-NP
level	level	NN	I-NP
of	of	IN	0
10	10	CD	0
-6	-6	CD	0
,	,	,	0
the	the	DT	0
number	number	NN	0
of	of	IN	0
false	false	JJ	0
positives	positives	NN	0
is	is	VBZ	0
expected	expected	VBN	0
to	to	TO	0
be	be	VB	0
0.015	0.015	CD	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
very	very	RB	0
small	small	JJ	0
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
in	in	IN	0
the	the	DT	0
above	above	IN	0
setting	setting	VBG	0
the	the	DT	0
chance	chance	NN	0
that	that	IN	0
at	at	IN	0
least	least	JJS	0
one	one	CD	0
of	of	IN	0
the	the	DT	0
15,154	15,154	CD	0
measurement	measurement	NN	B-NP
would	would	MD	0
have	have	VB	0
a	a	DT	0
p-value	p-value	JJ	B-NP
less	less	JJR	0
than	than	IN	0
10	10	CD	0
-6is	-6is	CD	0
approximately	approximately	CD	0
1.5	1.5	CD	0
%	%	NN	0
.	.	.	0
Thus	Thus	RB	0
it	it	PRP	0
is	is	VBZ	0
extremely	extremely	RB	0
unlikely	unlikely	JJ	0
that	that	IN	0
a	a	DT	0
false	false	JJ	0
positive	positive	NN	0
would	would	MD	0
occur	occur	VB	0
by	by	IN	0
chance	chance	NN	0
alone	alone	RB	0
in	in	IN	0
a	a	DT	0
15,154	15,154	JJ	0
member	member	NN	0
test	test	NN	0
set	set	NN	0
.	.	.	0
The	The	DT	0
finding	finding	NN	0
of	of	IN	0
significant	significant	JJ	0
signals	signals	NNS	0
at	at	IN	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
less	less	JJR	0
than	than	IN	0
500	500	CD	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
two	two	CD	0
of	of	IN	0
the	the	DT	0
seven	seven	CD	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
used	used	VBN	0
in	in	IN	0
the	the	DT	0
model	model	NN	B-NP
rule	rule	NN	I-NP
published	published	VBN	0
at	at	IN	0
the	the	DT	0
Clinical	Clinical	NNP	B-NP
Proteomics	Proteomics	NNP	I-NP
Program	Program	NNP	I-NP
Databank	Databank	NNP	I-NP
website	website	NN	I-NP
that	that	WDT	0
was	was	VBD	0
developed	developed	VBN	0
on	on	IN	0
the	the	DT	0
same	same	JJ	0
data	data	NNS	0
set	set	VBN	0
(	(	-LRB-	0
see	see	VB	0
Table	Table	NNP	0
4	4	CD	0
)	)	-RRB-	0
,	,	,	0
specifically	specifically	RB	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
435.46452	435.46452	NNP	0
(	(	-LRB-	0
p-value	p-value	NNP	B-NP
=	=	SYM	0
9.08	9.08	CD	0
×	×	CD	0
10	10	CD	0
-372	-372	CD	0
ndmost	ndmost	CD	B-NP
significant	significant	JJ	0
of	of	IN	0
9	9	CD	0
values	values	NNS	0
in	in	IN	0
its	its	PRP$	0
bin	bin	NN	0
)	)	-RRB-	0
and	and	CC	0
465.56916	465.56916	NNP	0
(	(	-LRB-	0
p-value	p-value	NNP	B-NP
=	=	SYM	0
2.50	2.50	CD	0
×	×	CD	0
10	10	CD	0
-286	-286	CD	0
thmost	thmost	CD	B-NP
significant	significant	JJ	0
of	of	IN	0
the	the	DT	0
7	7	CD	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
found	found	VBN	0
in	in	IN	0
its	its	PRP$	0
bin	bin	NN	0
)	)	-RRB-	0
[	[	-LRB-	0
7	7	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
values	values	NNS	0
correspond	correspond	VBP	0
to	to	TO	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
435.0751	435.0751	NNP	0
and	and	CC	0
464.3617	464.3617	RB	0
used	used	VBN	0
in	in	IN	0
Rule	Rule	NNP	0
1	1	CD	0
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
3	3	CD	0
,	,	,	0
each	each	DT	0
of	of	IN	0
these	these	DT	0
two	two	CD	0
pairs	pairs	NNS	0
of	of	IN	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
are	are	VBP	0
surprisingly	surprisingly	RB	0
effective	effective	JJ	0
at	at	IN	0
separating	separating	VBG	0
the	the	DT	0
162	162	CD	0
cancer	cancer	NN	B-NP
subject	subject	JJ	I-NP
from	from	IN	0
the	the	DT	0
91	91	CD	0
control	control	NN	B-NP
subject	subject	JJ	I-NP
with	with	IN	0
an	an	DT	0
advantage	advantage	NN	0
noted	noted	VBD	0
with	with	IN	0
the	the	DT	0
first	first	JJ	0
pair	pair	NN	0
(	(	-LRB-	0
compare	compare	VB	0
panel	panel	NN	0
A	A	NN	0
with	with	IN	0
B	B	NNP	0
)	)	-RRB-	0
.	.	.	0
Even	Even	RB	0
more	more	RBR	0
interesting	interesting	JJ	0
is	is	VBZ	0
the	the	DT	0
finding	finding	NN	0
that	that	IN	0
significant	significant	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
found	found	VBN	0
in	in	IN	0
the	the	DT	0
first	first	JJ	0
Rule	Rule	NNP	0
1	1	CD	0
included	included	VBD	0
the	the	DT	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
2.7921478	2.7921478	NNP	0
and	and	CC	0
245.53704	245.53704	NNP	0
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Figure	Figure	NNP	0
3	3	CD	0
,	,	,	0
panel	panel	NN	0
C	C	NNP	0
,	,	,	0
these	these	DT	0
two	two	CD	0
values	values	NNS	0
can	can	MD	0
also	also	RB	0
significantly	significantly	RB	0
separate	separate	VB	0
the	the	DT	0
162	162	CD	0
cancer	cancer	NN	B-NP
subject	subject	JJ	I-NP
from	from	IN	0
the	the	DT	0
91	91	CD	0
control	control	NN	B-NP
subject	subject	JJ	I-NP
.	.	.	0
The	The	DT	0
interpretation	interpretation	NN	B-NP
of	of	IN	0
these	these	DT	0
values	values	NNS	0
is	is	VBZ	0
problematic	problematic	JJ	0
,	,	,	0
given	given	VBN	0
the	the	DT	0
low	low	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
involved	involved	VBN	0
.	.	.	0
In	In	IN	0
order	order	NN	0
to	to	TO	0
evaluate	evaluate	VB	0
these	these	DT	0
findings	findings	NNS	0
,	,	,	0
we	we	PRP	0
first	first	RB	0
investigated	investigated	VBN	0
whether	whether	IN	0
data	data	NNS	0
normalization	normalization	VBP	0
as	as	RB	0
described	described	VBN	0
at	at	IN	0
the	the	DT	0
Clinical	Clinical	NNP	B-NP
Proteomics	Proteomics	NNP	I-NP
Data	Data	NNP	I-NP
Bank	Bank	NNP	I-NP
[	[	-LRB-	0
5	5	LS	0
]	]	-RRB-	0
could	could	MD	0
influence	influence	VB	0
the	the	DT	0
wilcoxon	wilcoxon	NNP	B-NP
test	test	NN	I-NP
p-value	p-value	NN	I-NP
found	found	VBD	0
using	using	VBG	0
the	the	DT	0
raw	raw	JJ	0
data	data	NNS	0
(	(	-LRB-	0
see	see	VB	0
methods	methods	NNS	0
)	)	-RRB-	0
.	.	.	0
Several	Several	JJ	0
points	points	NNS	0
were	were	VBD	0
chosen	chosen	VBN	0
,	,	,	0
and	and	CC	0
no	no	DT	0
effect	effect	NN	0
was	was	VBD	0
noted	noted	VBN	0
on	on	IN	0
the	the	DT	0
p-value	p-value	NN	B-NP
(	(	-LRB-	0
see	see	VB	0
Table	Table	NNP	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
further	further	RB	0
analyzed	analyzed	VBD	0
several	several	JJ	0
selected	selected	JJ	0
low	low	JJ	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
,	,	,	0
less	less	JJR	0
than	than	IN	0
500	500	CD	0
.	.	.	0
In	In	IN	0
this	this	DT	0
process	process	NN	0
,	,	,	0
the	the	DT	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	B-NP
data	data	NN	I-NP
were	were	VBD	0
pooled	pooled	VBN	0
.	.	.	0
The	The	DT	0
pooled	pooled	JJ	0
data	data	NNS	0
were	were	VBD	0
randomly	randomly	RB	0
partitioned	partitioned	VBN	0
between	between	IN	0
a	a	DT	0
set	set	VBN	0
containing	containing	VBG	0
91	91	CD	0
members	members	NNS	0
and	and	CC	0
a	a	DT	0
set	set	VBN	0
containing	containing	VBG	0
162	162	CD	0
members	members	NNS	0
.	.	.	0
The	The	DT	0
Wilcoxon	Wilcoxon	JJ	B-NP
test	test	NN	I-NP
was	was	VBD	0
then	then	RB	0
run	run	VBN	0
on	on	IN	0
the	the	DT	0
randomized	randomized	JJ	B-NP
set	set	NN	I-NP
.	.	.	0
The	The	DT	0
process	process	NN	0
was	was	VBD	0
repeated	repeated	VBN	0
10,000	10,000	CD	0
times	times	NNS	0
,	,	,	0
and	and	CC	0
the	the	DT	0
lowest	lowest	JJS	0
p-value	p-value	NN	B-NP
were	were	VBD	0
chosen	chosen	VBN	0
.	.	.	0
As	As	RB	0
shown	shown	VBN	0
in	in	IN	0
Table	Table	NNP	0
5	5	CD	0
,	,	,	0
the	the	DT	0
lowest	lowest	JJS	0
p-values	p-values	JJ	B-NP
generated	generated	NN	I-NP
by	by	IN	0
the	the	DT	0
permutation	permutation	JJ	B-NP
process	process	NN	I-NP
were	were	VBD	0
on	on	IN	0
the	the	DT	0
order	order	NN	0
of	of	IN	0
0.0001	0.0001	NNP	0
,	,	,	0
as	as	RB	0
expected	expected	VBN	0
given	given	VBN	0
the	the	DT	0
number	number	NN	0
of	of	IN	0
permutation	permutation	NN	B-NP
tested	tested	NN	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
highly	highly	RB	0
unlikely	unlikely	JJ	0
that	that	IN	0
either	either	DT	0
data	data	NN	0
normalization	normalization	NNS	0
or	or	CC	0
a	a	DT	0
chance	chance	NN	B-NP
distribution	distribution	NN	I-NP
could	could	MD	0
have	have	VB	0
accounted	accounted	VBN	0
for	for	IN	0
the	the	DT	0
highly	highly	RB	0
significant	significant	JJ	0
p-value	p-value	NN	B-NP
noted	noted	VBD	0
in	in	IN	0
the	the	DT	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
region	region	NN	I-NP
less	less	RBR	0
than	than	IN	0
500	500	CD	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
interesting	interesting	JJ	0
to	to	TO	0
note	note	VB	0
that	that	IN	0
the	the	DT	0
remaining	remaining	JJ	0
five	five	CD	0
values	values	NNS	0
in	in	IN	0
the	the	DT	0
Clinical	Clinical	NNP	B-NP
Proteomics	Proteomics	NNP	I-NP
Program	Program	NNP	I-NP
Databank	Databank	NNP	I-NP
model	model	NN	I-NP
rule	rule	NN	I-NP
all	all	RB	0
have	have	VB	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
greater	greater	JJR	0
than	than	IN	0
2000	2000	CD	0
and	and	CC	0
relatively	relatively	RB	0
high	high	JJ	0
p-value	p-value	NN	B-NP
.	.	.	0
Specifically	Specifically	RB	0
the	the	DT	0
remaining	remaining	JJ	0
values	values	NNS	0
are	are	VBP	0
(	(	-LRB-	0
note	note	NN	0
that	that	IN	0
the	the	DT	0
p-value	p-value	NN	B-NP
are	are	VBP	0
calculated	calculated	VBN	0
from	from	IN	0
the	the	DT	0
entire	entire	JJ	0
data	data	NNS	0
set	set	VBN	0
)	)	-RRB-	0
:	:	:	0
1	1	LS	0
)	)	-RRB-	0
M	M	NNP	0
/	/	NNP	0
Z	Z	NNP	0
=	=	SYM	0
2760.6685	2760.6685	CD	0
,	,	,	0
p	p	VBG	0
=	=	SYM	0
0.24	0.24	CD	0
2	2	CD	0
)	)	-RRB-	0
M	M	NNP	0
/	/	NNP	0
Z	Z	NNP	0
=	=	SYM	0
19643.409	19643.409	CD	0
,	,	,	0
p	p	VBG	0
=	=	SYM	0
0.52	0.52	CD	0
3	3	CD	0
)	)	-RRB-	0
M	M	NNP	0
/	/	NNP	0
Z	Z	NNP	0
=	=	SYM	0
6631.7043	6631.7043	CD	0
,	,	,	0
p	p	VBG	0
=	=	SYM	0
9.0	9.0	CD	0
×	×	CD	0
10	10	CD	0
-4	-4	CD	0
4	4	CD	0
)	)	-RRB-	0
M	M	NNP	0
/	/	NNP	0
Z	Z	NNP	0
=	=	SYM	0
14051.976	14051.976	CD	0
,	,	,	0
p	p	VBG	0
=	=	SYM	0
1.8	1.8	CD	0
×	×	CD	0
10	10	CD	0
-8	-8	CD	0
5	5	CD	0
)	)	-RRB-	0
M	M	NNP	0
/	/	NNP	0
Z	Z	NNP	0
=	=	SYM	0
3497.5508	3497.5508	CD	0
,	,	,	0
p	p	VBG	0
=	=	SYM	0
1.4	1.4	CD	0
×	×	CD	0
10	10	CD	0
-6	-6	CD	0
By	By	IN	0
contrast	contrast	NN	0
all	all	PDT	0
the	the	DT	0
M	M	NNP	0
/	/	NNP	0
Z	Z	NNP	0
values	values	VBZ	0
used	used	VBN	0
in	in	IN	0
Rule	Rule	NNP	0
1	1	CD	0
have	have	VBP	0
p-values	p-values	JJ	0
less	less	JJR	0
than	than	IN	0
10	10	CD	0
-26	-26	CD	0
(	(	-LRB-	0
compare	compare	VB	0
Table	Table	NNP	0
1with	1with	NNP	0
Table	Table	NNP	0
4	4	CD	0
)	)	-RRB-	0
.	.	.	0
There	There	EX	0
are	are	VBP	0
several	several	JJ	0
non-exclusive	non-exclusive	JJ	B-NP
explanation	explanation	NN	I-NP
for	for	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
significant	significant	JJ	0
p-value	p-value	NN	B-NP
in	in	IN	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
region	region	NN	I-NP
less	less	RBR	0
than	than	IN	0
500	500	CD	0
.	.	.	0
First	First	NNP	0
,	,	,	0
these	these	DT	0
may	may	MD	0
actually	actually	RB	0
represent	represent	VB	0
biomarkers	biomarkers	VBN	0
that	that	IN	0
correlate	correlate	NN	0
with	with	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
.	.	.	0
The	The	DT	0
disease	disease	NN	B-NP
process	process	NN	I-NP
may	may	MD	0
influence	influence	VB	0
the	the	DT	0
lipid	lipid	NN	B-NP
serum	serum	JJ	I-NP
concentration	concentration	NN	I-NP
,	,	,	0
or	or	CC	0
other	other	JJ	0
small	small	JJ	0
molecules	molecules	NNS	0
that	that	IN	0
either	either	DT	0
bind	bind	NN	0
to	to	TO	0
the	the	DT	0
chip	chip	NN	0
directly	directly	RB	0
or	or	CC	0
through	through	IN	0
a	a	DT	0
complex	complex	JJ	0
formation	formation	NN	0
with	with	IN	0
other	other	JJ	0
macromolecule	macromolecule	NN	B-NP
(	(	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
binding	binding	VBG	0
to	to	TO	0
a	a	DT	0
receptor	receptor	NN	B-NP
)	)	-RRB-	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
the	the	DT	0
lysophospholipid	lysophospholipid	NN	B-NP
represent	represent	VBP	0
a	a	DT	0
class	class	NN	0
of	of	IN	0
compounds	compounds	NNS	0
that	that	WDT	0
have	have	VBP	0
an	an	DT	0
important	important	JJ	0
role	role	NN	0
in	in	IN	0
extracellular	extracellular	JJ	B-NP
signaling	signaling	NN	I-NP
.	.	.	0
Lysophophatidic	Lysophophatidic	NNP	B-NP
Acid	Acid	NNP	I-NP
(	(	-LRB-	0
LPA	LPA	NNP	B-NP
)	)	-RRB-	0
is	is	VBZ	0
a	a	DT	0
member	member	NN	0
of	of	IN	0
this	this	DT	0
class	class	NN	0
of	of	IN	0
compounds	compounds	NN	0
,	,	,	0
and	and	CC	0
its	its	PRP$	0
plasma	plasma	JJ	B-NP
level	level	JJ	I-NP
have	have	VBP	0
been	been	VBN	0
proposed	proposed	VBN	0
as	as	IN	0
a	a	DT	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
potential	potential	JJ	I-NP
biomarker	biomarker	NN	I-NP
[	[	-LRB-	0
16	16	CD	0
17	17	CD	0
]	]	-RRB-	0
.	.	.	0
lysophophatidic	lysophophatidic	NN	B-NP
acid	acid	JJ	I-NP
is	is	VBZ	0
a	a	DT	0
family	family	NN	0
of	of	IN	0
related	related	JJ	0
molecules	molecules	NNS	0
with	with	IN	0
molecular	molecular	JJ	B-NP
weight	weight	NN	I-NP
in	in	IN	0
the	the	DT	0
vicinity	vicinity	NN	0
of	of	IN	0
400	400	CD	0
to	to	TO	0
600	600	CD	0
dalton	dalton	NNP	B-NP
,	,	,	0
and	and	CC	0
a	a	DT	0
variety	variety	NN	0
of	of	IN	0
LPA	LPA	NNP	B-NP
species	species	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
reported	reported	VBN	0
to	to	TO	0
be	be	VB	0
increased	increased	VBN	0
in	in	IN	0
malignant	malignant	JJ	0
ascite	ascite	NN	B-NP
from	from	IN	0
patients	patients	NNS	0
with	with	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
as	as	IN	0
detected	detected	VBN	0
by	by	IN	0
electrospray	electrospray	NN	B-NP
ionization	ionization	NN	I-NP
mass	mass	NN	I-NP
spectrometry	spectrometry	NN	I-NP
(	(	-LRB-	0
ESI-MS	ESI-MS	NNP	B-NP
)	)	-RRB-	0
[	[	-LRB-	0
18	18	CD	0
]	]	-RRB-	0
.	.	.	0
lysophophatidic	lysophophatidic	NN	B-NP
acid	acid	JJ	I-NP
related	related	JJ	0
specie	specie	NN	B-NP
have	have	VBP	0
also	also	RB	0
been	been	VBN	0
reported	reported	VBN	0
to	to	TO	0
be	be	VB	0
increased	increased	VBN	0
in	in	IN	0
plasma	plasma	JJ	0
samples	samples	NNS	0
from	from	IN	0
patients	patients	NNS	0
with	with	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
using	using	VBG	0
a	a	DT	0
combination	combination	NN	0
of	of	IN	0
thin	thin	JJ	0
layer	layer	NN	B-NP
chromatography	chromatography	NN	I-NP
(	(	-LRB-	0
to	to	TO	0
isolate	isolate	VB	0
an	an	DT	0
"LPA	"LPA	JJ	0
band	band	NN	0
"	"	''	0
from	from	IN	0
patient	patient	JJ	0
plasma	plasma	NN	B-NP
)	)	-RRB-	0
followed	followed	VBD	0
by	by	IN	0
electrospray	electrospray	NN	B-NP
ionization	ionization	NN	I-NP
mass	mass	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
spectrometry	spectrometry	NN	I-NP
.	.	.	0
This	This	DT	0
study	study	NN	0
reported	reported	VBD	0
significant	significant	JJ	0
lpa	lpa	NN	B-NP
increase	increase	NN	I-NP
in	in	IN	0
cancer	cancer	NN	B-NP
sample	sample	NN	I-NP
with	with	IN	0
increased	increased	JJ	0
intensities	intensities	NN	0
noted	noted	VBD	0
at	at	IN	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
409	409	CD	0
,	,	,	0
433-437	433-437	NNP	0
,	,	,	0
457	457	CD	0
,	,	,	0
481-482	481-482	NNP	0
,	,	,	0
571	571	CD	0
,	,	,	0
599	599	CD	0
,	,	,	0
and	and	CC	0
619	619	CD	0
.	.	.	0
This	This	DT	0
report	report	NN	0
also	also	RB	0
reviews	reviews	VBZ	0
the	the	DT	0
evidence	evidence	NN	0
that	that	IN	0
these	these	DT	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
are	are	VBP	0
consistent	consistent	JJ	0
with	with	IN	0
lpa	lpa	NN	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
[	[	-LRB-	0
19	19	CD	0
]	]	-RRB-	0
.	.	.	0
Figure	Figure	NN	0
4shows	4shows	VBZ	0
the	the	DT	0
average	average	JJ	0
intensities	intensities	NN	0
and	and	CC	0
p-value	p-value	NN	B-NP
for	for	IN	0
both	both	PDT	0
the	the	DT	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	B-NP
group	group	NN	I-NP
in	in	IN	0
the	the	DT	0
region	region	NN	0
between	between	IN	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
410	410	CD	0
to	to	TO	0
470	470	CD	0
.	.	.	0
Among	Among	IN	0
other	other	JJ	0
features	features	NNS	0
,	,	,	0
an	an	DT	0
increase	increase	NN	0
in	in	IN	0
the	the	DT	0
mean	mean	JJ	0
intensity	intensity	NN	0
for	for	IN	0
cancers	cancers	NNS	0
at	at	IN	0
a	a	DT	0
peak	peak	NN	0
centered	centered	VBN	0
at	at	IN	0
an	an	DT	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
of	of	IN	0
459	459	CD	0
is	is	VBZ	0
noted	noted	VBN	0
.	.	.	0
However	However	RB	0
,	,	,	0
also	also	RB	0
of	of	IN	0
note	note	NN	0
in	in	IN	0
this	this	DT	0
region	region	NN	0
are	are	VBP	0
:	:	:	0
1	1	LS	0
)	)	-RRB-	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
=	=	SYM	0
464.3617	464.3617	CD	0
with	with	IN	0
a	a	DT	0
p-value	p-value	JJ	B-NP
less	less	JJR	0
than	than	IN	0
6.8	6.8	CD	0
×	×	CD	0
10	10	CD	0
-35	-35	CD	0
,	,	,	0
that	that	WDT	0
correlates	correlates	VBZ	0
with	with	IN	0
a	a	DT	0
shoulder	shoulder	NN	0
in	in	IN	0
a	a	DT	0
secondary	secondary	JJ	B-NP
peak	peak	NN	I-NP
at	at	IN	0
about	about	IN	0
463	463	CD	0
,	,	,	0
that	that	WDT	0
is	is	VBZ	0
decreased	decreased	VBN	0
in	in	IN	0
cancer	cancer	NN	B-NP
patient	patient	JJ	I-NP
(	(	-LRB-	0
average	average	JJ	0
intensity	intensity	NN	0
17.5	17.5	CD	0
for	for	IN	0
cancer	cancer	NN	0
versus	versus	IN	0
23.6	23.6	CD	0
for	for	IN	0
controls	controls	NNS	0
)	)	-RRB-	0
.	.	.	0
2	2	LS	0
)	)	-RRB-	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
=	=	SYM	0
435.0751	435.0751	CD	0
with	with	IN	0
a	a	DT	0
p-value	p-value	JJ	B-NP
of	of	IN	0
less	less	JJR	0
than	than	IN	0
3.9	3.9	CD	0
×	×	CD	0
10	10	CD	0
-37	-37	CD	0
,	,	,	0
that	that	WDT	0
corresponds	corresponds	VBZ	0
to	to	TO	0
a	a	DT	0
peak	peak	NN	0
with	with	IN	0
increased	increased	JJ	0
intensity	intensity	NN	0
in	in	IN	0
cancer	cancer	NN	0
(	(	-LRB-	0
average	average	JJ	0
intensity	intensity	NN	0
33	33	CD	0
for	for	IN	0
cancer	cancer	NN	0
versus	versus	IN	0
25.5	25.5	CD	0
for	for	IN	0
controls	controls	NNS	0
)	)	-RRB-	0
.	.	.	0
3	3	LS	0
)	)	-RRB-	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
=	=	SYM	0
417.73207	417.73207	CD	0
with	with	IN	0
a	a	DT	0
p-value	p-value	JJ	B-NP
less	less	JJR	0
than	than	IN	0
6.2	6.2	CD	0
×	×	CD	0
10	10	CD	0
-35	-35	CD	0
,	,	,	0
that	that	WDT	0
corresponds	corresponds	VBZ	0
to	to	TO	0
a	a	DT	0
peak	peak	NN	0
that	that	WDT	0
is	is	VBZ	0
decreased	decreased	VBN	0
in	in	IN	0
cancer	cancer	NN	0
(	(	-LRB-	0
average	average	JJ	0
intensity	intensity	NN	0
39.5	39.5	CD	0
for	for	IN	0
cancer	cancer	NN	0
versus	versus	IN	0
47.4	47.4	CD	0
for	for	IN	0
controls	controls	NNS	0
)	)	-RRB-	0
The	The	DT	0
identity	identity	NN	0
of	of	IN	0
the	the	DT	0
molecules	molecules	JJ	0
responsible	responsible	JJ	0
for	for	IN	0
these	these	DT	0
differences	differences	NNS	0
cannot	cannot	RB	0
be	be	VB	0
determined	determined	VBN	0
from	from	IN	0
this	this	DT	0
data	data	NNS	0
.	.	.	0
However	However	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
in	in	IN	0
some	some	DT	0
cases	cases	NNS	0
they	they	PRP	0
may	may	MD	0
relate	relate	VB	0
to	to	TO	0
the	the	DT	0
LPA	LPA	NNP	B-NP
family	family	NN	I-NP
of	of	IN	0
molecules	molecules	NNS	0
,	,	,	0
or	or	CC	0
to	to	TO	0
alterations	alterations	VB	0
in	in	IN	0
proteins	proteins	NNS	0
that	that	IN	0
bind	bind	JJ	B-NP
lpa	lpa	NN	I-NP
family	family	NN	I-NP
member	member	NN	I-NP
.	.	.	0
Other	Other	JJ	0
explanations	explanations	NNS	0
for	for	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
statistically	statistically	JJ	0
significant	significant	JJ	0
bands	bands	NNS	0
of	of	IN	0
low	low	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
include	include	VBP	0
degradation	degradation	JJ	B-NP
product	product	NN	I-NP
of	of	IN	0
higher	higher	JJR	0
molecular	molecular	JJ	B-NP
weight	weight	NN	I-NP
macromolecule	macromolecule	NN	I-NP
or	or	CC	0
a	a	DT	0
matrix	matrix	JJ	B-NP
effect	effect	NN	I-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
if	if	IN	0
a	a	DT	0
set	set	NN	0
of	of	IN	0
proteins	proteins	NNS	0
exist	exist	VBP	0
that	that	WDT	0
are	are	VBP	0
expressed	expressed	VBN	0
at	at	IN	0
different	different	JJ	0
levels	levels	NNS	0
between	between	IN	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	B-NP
subject	subject	JJ	I-NP
but	but	CC	0
have	have	VB	0
a	a	DT	0
common	common	JJ	0
domain	domain	NN	0
,	,	,	0
then	then	RB	0
a	a	DT	0
common	common	JJ	0
product	product	NN	B-NP
ion	ion	NN	I-NP
of	of	IN	0
lower	lower	JJR	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
may	may	MD	0
be	be	VB	0
generated	generated	VBN	0
that	that	WDT	0
would	would	MD	0
represent	represent	VB	0
a	a	DT	0
summation	summation	NN	0
of	of	IN	0
all	all	PDT	0
the	the	DT	0
changes	changes	NNS	0
in	in	IN	0
expression	expression	NN	0
of	of	IN	0
the	the	DT	0
group	group	NN	0
of	of	IN	0
proteins	proteins	NNS	0
,	,	,	0
and	and	CC	0
might	might	MD	0
thus	thus	RB	0
have	have	VB	0
greater	greater	JJR	0
statistical	statistical	JJ	B-NP
significance	significance	NN	I-NP
than	than	IN	0
the	the	DT	0
changes	changes	NNS	0
associated	associated	VBN	0
with	with	IN	0
any	any	DT	0
single	single	JJ	0
high	high	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
value	value	NN	I-NP
.	.	.	0
Similarly	Similarly	RB	0
,	,	,	0
a	a	DT	0
set	set	NN	0
of	of	IN	0
low	low	JJ	0
m/z	m/z	NN	B-NP
molecule	molecule	NN	I-NP
(	(	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
energy-absorbing	energy-absorbing	JJ	0
molecule	molecule	NN	B-NP
or	or	CC	0
matrix	matrix	CD	B-NP
)	)	-RRB-	0
that	that	WDT	0
interacts	interacts	VBP	0
differently	differently	RB	0
in	in	IN	0
a	a	DT	0
protein	protein	NN	0
environment	environment	NN	0
that	that	WDT	0
differs	differs	VBZ	0
markedly	markedly	RB	0
between	between	IN	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	0
could	could	MD	0
hypothetically	hypothetically	RB	0
generate	generate	VB	0
a	a	DT	0
similar	similar	JJ	0
phenomenon	phenomenon	NN	0
.	.	.	0
However	However	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
difficult	difficult	JJ	0
to	to	TO	0
apply	apply	VB	0
any	any	DT	0
of	of	IN	0
the	the	DT	0
above	above	JJ	0
explanation	explanation	NN	B-NP
to	to	TO	0
the	the	DT	0
very	very	RB	0
low	low	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
such	such	JJ	0
as	as	IN	0
2.7921478	2.7921478	NNP	0
and	and	CC	0
245.53704	245.53704	NNP	0
,	,	,	0
although	although	IN	0
in	in	IN	0
the	the	DT	0
last	last	JJ	0
case	case	NN	0
an	an	DT	0
extremely	extremely	RB	0
small	small	JJ	0
organic	organic	JJ	B-NP
molecule	molecule	NN	I-NP
is	is	VBZ	0
possible	possible	JJ	0
.	.	.	0
Alternatively	Alternatively	RB	0
,	,	,	0
there	there	EX	0
maybe	maybe	RB	0
some	some	DT	0
unexpected	unexpected	JJ	0
experimental	experimental	JJ	B-NP
bias	bias	NN	I-NP
or	or	CC	0
systematic	systematic	JJ	B-NP
error	error	NN	I-NP
that	that	IN	0
accounts	accounts	NNS	0
for	for	IN	0
low	low	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
discrimination	discrimination	NN	I-NP
.	.	.	0
This	This	DT	0
could	could	MD	0
occur	occur	VB	0
at	at	IN	0
any	any	DT	0
experimental	experimental	JJ	B-NP
step	step	NN	I-NP
,	,	,	0
and	and	CC	0
might	might	MD	0
include	include	VB	0
medication	medication	NN	0
or	or	CC	0
lifestyle	lifestyle	JJ	B-NP
change	change	NN	I-NP
that	that	WDT	0
occurs	occurs	VBZ	0
in	in	IN	0
patients	patients	NNS	0
who	who	WP	0
learn	learn	VBP	0
they	they	PRP	0
have	have	VBP	0
a	a	DT	0
cancer	cancer	NN	B-NP
diagnosis	diagnosis	NN	I-NP
,	,	,	0
variation	variation	NN	0
in	in	IN	0
sample	sample	NN	0
collection	collection	NN	0
,	,	,	0
processing	processing	NN	0
and	and	CC	0
preservation	preservation	NN	B-NP
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
bias	bias	NN	0
introduced	introduced	VBN	0
at	at	IN	0
the	the	DT	0
time	time	NN	0
of	of	IN	0
analysis	analysis	NN	0
.	.	.	0
In	In	IN	0
the	the	DT	0
case	case	NN	0
of	of	IN	0
lysophophatidic	lysophophatidic	NN	B-NP
acid	acid	JJ	I-NP
,	,	,	0
increased	increased	VBD	B-NP
plasma	plasma	JJ	I-NP
level	level	JJ	I-NP
may	may	MD	0
be	be	VB	0
associated	associated	VBN	0
with	with	IN	0
platelet	platelet	JJ	B-NP
activation	activation	NN	I-NP
.	.	.	0
Another	Another	DT	0
group	group	NN	0
trying	trying	VBG	0
to	to	TO	0
repeat	repeat	VB	0
the	the	DT	0
observation	observation	NN	B-NP
of	of	IN	0
increased	increased	JJ	0
levels	levels	NNS	0
of	of	IN	0
lysophophatidic	lysophophatidic	NN	B-NP
acid	acid	JJ	I-NP
associated	associated	VBN	0
with	with	IN	0
ovarian	ovarian	JJ	B-NP
cancer	cancer	NN	I-NP
concluded	concluded	VBD	0
that	that	IN	0
there	there	EX	0
was	was	VBD	0
no	no	DT	0
diagnostic	diagnostic	JJ	B-NP
value	value	NN	I-NP
in	in	IN	0
the	the	DT	0
assay	assay	NN	B-NP
,	,	,	0
and	and	CC	0
attributed	attributed	VBD	0
the	the	DT	0
discrepant	discrepant	JJ	B-NP
finding	finding	NN	I-NP
as	as	IN	0
possibly	possibly	RB	0
related	related	VBN	0
to	to	TO	0
different	different	JJ	0
sample	sample	NN	B-NP
centrifugation	centrifugation	NNS	I-NP
protocol	protocol	NN	I-NP
used	used	VBN	0
by	by	IN	0
the	the	DT	0
two	two	CD	0
groups	groups	NNS	0
to	to	TO	0
remove	remove	VB	0
platelets	platelets	VBN	0
from	from	IN	0
the	the	DT	0
samples	samples	NNS	0
prior	prior	RB	0
to	to	TO	0
analysis	analysis	NN	0
[	[	-LRB-	0
20	20	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
lysophophatidic	lysophophatidic	NN	B-NP
acid	acid	JJ	I-NP
continues	continues	VBZ	0
to	to	TO	0
be	be	VB	0
actively	actively	RB	0
evaluated	evaluated	VBN	0
for	for	IN	0
its	its	PRP$	0
clinical	clinical	JJ	B-NP
utility	utility	NN	I-NP
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
Conclusions	Conclusions	FW	0
Serum	Serum	NN	B-NP
proteomic	proteomic	NN	I-NP
profiling	profiling	FW	0
is	is	VBZ	0
a	a	DT	0
new	new	JJ	0
approach	approach	NN	0
to	to	TO	0
cancer	cancer	NN	B-NP
diagnosis	diagnosis	NN	I-NP
.	.	.	0
However	However	RB	0
it	it	PRP	0
confronts	confronts	VBZ	0
a	a	DT	0
challenging	challenging	JJ	0
environment	environment	NN	0
,	,	,	0
as	as	IN	0
it	it	PRP	0
combines	combines	VBZ	0
measurement	measurement	JJ	B-NP
technology	technology	NN	I-NP
that	that	WDT	0
are	are	VBP	0
new	new	JJ	0
in	in	IN	0
the	the	DT	0
clinical	clinical	JJ	B-NP
setting	setting	NN	I-NP
with	with	IN	0
novel	novel	NN	0
approaches	approaches	NNS	0
to	to	TO	0
processing	processing	NN	0
and	and	CC	0
interpreting	interpreting	VBG	0
high	high	JJ	0
dimensional	dimensional	JJ	B-NP
data	data	NN	I-NP
.	.	.	0
Further	Further	RB	0
,	,	,	0
controlling	controlling	VBG	0
large	large	JJ	0
clinical	clinical	JJ	B-NP
study	study	NN	I-NP
can	can	MD	0
be	be	VB	0
challenging	challenging	VBG	0
even	even	RB	0
in	in	IN	0
more	more	RBR	0
established	established	JJ	0
settings	settings	NNS	0
.	.	.	0
Nevertheless	Nevertheless	RB	0
,	,	,	0
it	it	PRP	0
represents	represents	VBZ	0
an	an	DT	0
advance	advance	NN	0
in	in	IN	0
the	the	DT	0
ability	ability	NN	B-NP
to	to	TO	0
diagnose	diagnose	VB	0
and	and	CC	0
understand	understand	VB	0
illness	illness	NN	0
.	.	.	0
The	The	DT	0
results	results	NNS	0
presented	presented	VBN	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
are	are	VBP	0
useful	useful	JJ	0
for	for	IN	0
several	several	JJ	0
reasons	reasons	NNS	0
.	.	.	0
First	First	NNP	0
,	,	,	0
in	in	IN	0
regard	regard	NN	0
to	to	TO	0
disease	disease	NN	B-NP
classification	classification	NN	I-NP
,	,	,	0
advanced	advanced	JJ	0
data	data	NN	0
mining	mining	NN	0
techniques	techniques	NNS	0
should	should	MD	0
be	be	VB	0
benchmarked	benchmarked	VBN	0
against	against	IN	0
traditional	traditional	JJ	0
methods	methods	NNS	0
when	when	WRB	0
possible	possible	JJ	0
.	.	.	0
Further	Further	RBR	0
identical	identical	JJ	0
training	training	NN	B-NP
set	set	NN	I-NP
should	should	MD	0
be	be	VB	0
defined	defined	VBN	0
for	for	IN	0
such	such	PDT	0
a	a	DT	0
comparison	comparison	NN	0
as	as	IN	0
results	results	NNS	0
may	may	MD	0
very	very	RB	0
depending	depending	VBG	0
on	on	IN	0
the	the	DT	0
samples	samples	NNS	0
chosen	chosen	VBN	0
for	for	IN	0
inclusion	inclusion	NN	0
in	in	IN	0
the	the	DT	0
training	training	NN	B-NP
set	set	NN	I-NP
.	.	.	0
The	The	DT	0
development	development	NN	0
of	of	IN	0
disease	disease	NN	0
classifiers	classifiers	VBZ	0
using	using	VBG	0
routine	routine	JJ	B-NP
analysis	analysis	NN	I-NP
proved	proved	VBD	0
to	to	TO	0
be	be	VB	0
straightforward	straightforward	JJ	0
,	,	,	0
and	and	CC	0
resulted	resulted	VBD	0
in	in	IN	0
excellent	excellent	JJ	0
performance	performance	NN	0
in	in	IN	0
both	both	PDT	0
the	the	DT	0
test	test	NN	0
and	and	CC	0
training	training	NN	B-NP
set	set	NN	I-NP
(	(	-LRB-	0
e.g.	e.g.	CD	0
100	100	CD	0
%	%	NN	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NN	0
for	for	IN	0
Rules	Rules	NNP	0
1	1	CD	0
and	and	CC	0
3	3	CD	0
in	in	IN	0
the	the	DT	0
first	first	JJ	0
training	training	NN	B-NP
set	set	NN	I-NP
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
particular	particular	JJ	0
these	these	DT	0
preliminary	preliminary	JJ	B-NP
data	data	NN	I-NP
suggest	suggest	VBP	0
that	that	IN	0
these	these	DT	0
two	two	CD	0
rules	rules	NNS	0
may	may	MD	0
be	be	VB	0
specific	specific	JJ	0
enough	enough	JJ	0
to	to	TO	0
scale	scale	VB	0
to	to	TO	0
larger	larger	JJR	0
population	population	NN	B-NP
trial	trial	NN	I-NP
without	without	IN	0
generating	generating	VBG	0
an	an	DT	0
unacceptably	unacceptably	JJ	0
high	high	JJ	0
false	false	JJ	0
positive	positive	JJ	B-NP
rate	rate	NN	I-NP
.	.	.	0
This	This	DT	0
study	study	NN	0
also	also	RB	0
confirms	confirms	VBZ	0
that	that	IN	0
a	a	DT	0
classifier	classifier	NN	B-NP
could	could	MD	0
be	be	VB	0
developed	developed	VBN	0
with	with	IN	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
greater	greater	JJR	0
than	than	IN	0
2000	2000	CD	0
.	.	.	0
This	This	DT	0
indicates	indicates	VBZ	0
that	that	DT	0
information	information	NN	0
regarding	regarding	VBG	0
the	the	DT	0
difference	difference	NN	0
between	between	IN	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	0
is	is	VBZ	0
present	present	JJ	0
throughout	throughout	IN	0
the	the	DT	0
entire	entire	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
region	region	NN	I-NP
studied	studied	VBD	0
,	,	,	0
a	a	DT	0
result	result	NN	0
entirely	entirely	RB	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
observed	observed	JJ	0
wilcoxon	wilcoxon	NNP	B-NP
test	test	NN	I-NP
p-value	p-value	NN	I-NP
.	.	.	0
Secondly	Secondly	RB	0
,	,	,	0
routine	routine	JJ	B-NP
analysis	analysis	NN	I-NP
allows	allows	VBZ	0
investigator	investigator	NN	B-NP
to	to	TO	0
rapidly	rapidly	RB	0
review	review	VB	0
the	the	DT	0
data	data	NNS	0
for	for	IN	0
their	their	PRP$	0
general	general	JJ	0
trends	trends	NNS	0
,	,	,	0
and	and	CC	0
correlate	correlate	VBG	0
the	the	DT	0
findings	findings	NNS	0
with	with	IN	0
other	other	JJ	0
information	information	NN	0
.	.	.	0
The	The	DT	0
findings	findings	NNS	0
of	of	IN	0
significant	significant	JJ	0
discrimination	discrimination	NN	B-NP
between	between	IN	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	B-NP
group	group	NN	I-NP
at	at	IN	0
low	low	JJ	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
indicates	indicates	VBZ	0
that	that	DT	0
attention	attention	NN	0
should	should	MD	0
be	be	VB	0
focused	focused	VBN	0
in	in	IN	0
this	this	DT	0
region	region	NN	0
.	.	.	0
In	In	IN	0
particular	particular	JJ	0
,	,	,	0
if	if	IN	0
experimental	experimental	JJ	B-NP
bias	bias	NN	I-NP
and	and	CC	0
noise	noise	NN	B-NP
effect	effect	NN	I-NP
can	can	MD	0
be	be	VB	0
excluded	excluded	VBN	0
,	,	,	0
this	this	DT	0
region	region	NN	0
may	may	MD	0
prove	prove	VB	0
to	to	TO	0
offer	offer	VB	0
the	the	DT	0
diagnostic	diagnostic	JJ	B-NP
test	test	NN	I-NP
development	development	NN	I-NP
ovarian	ovarian	JJ	I-NP
cancer	cancer	NN	I-NP
optimum	optimum	NN	I-NP
.	.	.	0
On	On	IN	0
the	the	DT	0
other	other	JJ	0
hand	hand	NN	0
,	,	,	0
if	if	IN	0
bias	bias	NN	0
cannot	cannot	RB	0
be	be	VB	0
excluded	excluded	VBN	0
,	,	,	0
the	the	DT	0
possibility	possibility	NN	0
must	must	MD	0
be	be	VB	0
entertained	entertained	VBN	0
that	that	IN	0
higher	higher	JJR	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
may	may	MD	0
also	also	RB	0
have	have	VBP	0
been	been	VBN	0
similarly	similarly	RB	0
affected	affected	VBN	0
.	.	.	0
In	In	IN	0
order	order	NN	0
to	to	TO	0
address	address	VB	0
these	these	DT	0
issues	issues	NNS	0
,	,	,	0
consideration	consideration	NN	B-NP
may	may	MD	0
be	be	VB	0
given	given	VBN	0
to	to	TO	0
using	using	VBG	0
mass	mass	JJ	0
spectrometry	spectrometry	JJ	B-NP
method	method	NN	I-NP
with	with	IN	0
increased	increased	JJ	0
sensitivity	sensitivity	NN	0
in	in	IN	0
the	the	DT	0
low	low	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
region	region	NN	I-NP
.	.	.	0
The	The	DT	0
experimental	experimental	JJ	B-NP
condition	condition	NN	I-NP
used	used	VBN	0
to	to	TO	0
physically	physically	VB	0
bind	bind	VBN	0
the	the	DT	0
serum	serum	JJ	0
samples	samples	NNS	0
to	to	TO	0
the	the	DT	0
chip	chip	NN	0
prior	prior	RB	0
to	to	TO	0
analysis	analysis	NN	0
may	may	MD	0
also	also	RB	0
prove	prove	VB	0
critical	critical	JJ	0
,	,	,	0
and	and	CC	0
should	should	MD	0
be	be	VB	0
consistent	consistent	JJ	0
with	with	IN	0
those	those	DT	0
used	used	VBN	0
in	in	IN	0
collecting	collecting	VBG	0
the	the	DT	0
current	current	JJ	0
data	data	NNS	0
set	set	VBN	0
.	.	.	0
Also	Also	RB	0
,	,	,	0
the	the	DT	0
possibility	possibility	NN	0
that	that	IN	0
the	the	DT	0
changes	changes	NNS	0
in	in	IN	0
the	the	DT	0
low	low	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
region	region	NN	I-NP
may	may	MD	0
represent	represent	VB	0
an	an	DT	0
additive	additive	JJ	B-NP
effect	effect	NN	I-NP
caused	caused	VBN	0
by	by	IN	0
differing	differing	VBG	B-NP
protein	protein	NN	I-NP
environment	environment	NN	I-NP
between	between	IN	0
cancer	cancer	NN	0
and	and	CC	0
normal	normal	JJ	0
may	may	MD	0
be	be	VB	0
approached	approached	VBN	0
by	by	IN	0
intentionally	intentionally	RB	0
spiking	spiking	JJ	0
samples	samples	NNS	0
with	with	IN	0
panels	panels	NNS	0
of	of	IN	0
known	known	JJ	0
proteins	proteins	NNS	0
,	,	,	0
and	and	CC	0
determining	determining	VBG	0
if	if	IN	0
there	there	EX	0
is	is	VBZ	0
an	an	DT	0
effect	effect	NN	0
on	on	IN	0
the	the	DT	0
spectra	spectra	NN	0
in	in	IN	0
the	the	DT	0
low	low	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
region	region	NN	I-NP
.	.	.	0
The	The	DT	0
use	use	NN	0
of	of	IN	0
internal	internal	JJ	B-NP
standard	standard	JJ	I-NP
to	to	TO	0
normalize	normalize	VB	0
this	this	DT	0
type	type	NN	0
of	of	IN	0
experimental	experimental	JJ	B-NP
system	system	NN	I-NP
in	in	IN	0
general	general	NN	0
may	may	MD	0
also	also	RB	0
be	be	VB	0
considered	considered	VBN	0
.	.	.	0
As	As	RB	0
with	with	IN	0
all	all	DT	0
clinical	clinical	JJ	B-NP
test	test	NN	I-NP
development	development	NN	I-NP
,	,	,	0
confirmation	confirmation	NN	B-NP
of	of	IN	0
results	results	NNS	0
in	in	IN	0
independent	independent	JJ	0
laboratories	laboratories	NNS	0
running	running	VBG	0
blinded	blinded	JJ	0
samples	samples	NNS	0
will	will	MD	0
remain	remain	VB	0
the	the	DT	0
gold	gold	NN	0
standard	standard	NN	0
in	in	IN	0
ruling	ruling	VBG	0
out	out	RP	0
the	the	DT	0
possible	possible	JJ	0
effects	effects	NNS	0
of	of	IN	0
bias	bias	NN	0
,	,	,	0
unless	unless	IN	0
the	the	DT	0
sample	sample	NN	0
set	set	VBD	0
itself	itself	PRP	0
contains	contains	VBZ	0
the	the	DT	0
bias	bias	NN	0
.	.	.	0
Particular	Particular	JJ	B-NP
attention	attention	NN	I-NP
should	should	MD	0
be	be	VB	0
paid	paid	VBN	0
to	to	TO	0
pre-analytic	pre-analytic	JJ	B-NP
cause	cause	NN	I-NP
of	of	IN	0
bias	bias	NN	0
that	that	WDT	0
may	may	MD	0
influence	influence	VB	0
the	the	DT	0
serum	serum	JJ	B-NP
proteome	proteome	NN	I-NP
.	.	.	0
In	In	IN	0
particular	particular	JJ	0
the	the	DT	0
coagulation	coagulation	NN	B-NP
and	and	CC	0
complement	complement	JJ	B-NP
system	system	NN	I-NP
should	should	MD	0
be	be	VB	0
considered	considered	VBN	0
as	as	IN	0
potential	potential	JJ	B-NP
source	source	NN	I-NP
of	of	IN	0
noise	noise	NN	0
in	in	IN	0
this	this	DT	0
context	context	NN	0
,	,	,	0
as	as	IN	0
both	both	DT	0
are	are	VBP	0
activated	activated	VBN	0
during	during	IN	0
serum	serum	JJ	B-NP
sample	sample	NN	I-NP
collection	collection	NN	I-NP
and	and	CC	0
generate	generate	VB	0
low	low	JJ	0
molecular	molecular	JJ	B-NP
weight	weight	NN	I-NP
product	product	NN	I-NP
.	.	.	0
These	These	DT	0
products	products	NNS	0
are	are	VBP	0
undesirable	undesirable	VBN	0
for	for	IN	0
two	two	CD	0
reasons	reasons	NNS	0
.	.	.	0
First	First	NNP	0
,	,	,	0
if	if	IN	0
a	a	DT	0
putative	putative	JJ	B-NP
tumor	tumor	NN	I-NP
biomarker	biomarker	NN	I-NP
(	(	-LRB-	0
e.g.	e.g.	NNP	0
lysophophatidic	lysophophatidic	NN	B-NP
acid	acid	JJ	I-NP
)	)	-RRB-	0
is	is	VBZ	0
a	a	DT	0
member	member	NN	0
of	of	IN	0
a	a	DT	0
pathway	pathway	NN	0
altered	altered	VBN	0
during	during	IN	0
serum	serum	JJ	B-NP
sample	sample	NN	I-NP
collection	collection	NN	I-NP
,	,	,	0
changes	changes	NNS	0
between	between	IN	0
plasma	plasma	JJ	B-NP
level	level	JJ	I-NP
of	of	IN	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	B-NP
subject	subject	JJ	I-NP
may	may	MD	0
be	be	VB	0
obscured	obscured	NNS	0
.	.	.	0
Secondly	Secondly	RB	0
,	,	,	0
the	the	DT	0
generation	generation	NN	0
of	of	IN	0
activation	activation	JJ	B-NP
product	product	NN	I-NP
may	may	MD	0
simply	simply	RB	0
complicate	complicate	VB	0
the	the	DT	0
spectrum	spectrum	NN	B-NP
.	.	.	0
Also	Also	RB	0
,	,	,	0
sample	sample	NN	0
collection	collection	NN	0
practices	practices	NNS	0
should	should	MD	0
be	be	VB	0
rigorously	rigorously	RB	0
defined	defined	VBN	0
,	,	,	0
and	and	CC	0
include	include	VBP	0
submitting	submitting	VBG	0
matched	matched	VBN	B-NP
control	control	NN	I-NP
and	and	CC	0
cancer	cancer	NN	B-NP
sample	sample	NN	I-NP
from	from	IN	0
all	all	DT	0
centers	centers	NNS	0
participating	participating	VBG	0
in	in	IN	0
the	the	DT	0
study	study	NN	0
.	.	.	0
Matching	Matching	VBG	0
for	for	IN	0
age	age	NN	0
and	and	CC	0
menopausal	menopausal	JJ	B-NP
status	status	NN	I-NP
should	should	MD	0
be	be	VB	0
considered	considered	VBN	0
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
in	in	IN	0
the	the	DT	0
data	data	NNS	0
set	set	VBD	0
used	used	VBN	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
,	,	,	0
the	the	DT	0
mean	mean	JJ	0
age	age	NN	0
of	of	IN	0
the	the	DT	0
control	control	NN	B-NP
group	group	NN	I-NP
was	was	VBD	0
47	47	CD	0
years	years	NNS	0
and	and	CC	0
the	the	DT	0
cancer	cancer	NN	B-NP
group	group	NN	I-NP
60	60	CD	0
years	years	NNS	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
noteworthy	noteworthy	VBN	0
that	that	IN	0
the	the	DT	0
average	average	JJ	0
age	age	NN	0
of	of	IN	0
menopause	menopause	NN	0
is	is	VBZ	0
approximately	approximately	RB	0
51	51	CD	0
years	years	NNS	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
may	may	MD	0
introduce	introduce	VB	0
a	a	DT	0
bias	bias	NN	0
in	in	IN	0
the	the	DT	0
results	results	NNS	0
reported	reported	VBD	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
as	as	IN	0
well	well	RB	0
as	as	IN	0
all	all	DT	0
others	others	NNS	0
derived	derived	VBN	0
from	from	IN	0
this	this	DT	0
dataset	dataset	NN	B-NP
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
the	the	DT	0
steps	steps	NNS	0
associated	associated	VBN	0
with	with	IN	0
sample	sample	NN	0
collection	collection	NN	0
,	,	,	0
processing	processing	NN	0
,	,	,	0
and	and	CC	0
binding	binding	VBG	0
to	to	TO	0
the	the	DT	0
chip	chip	NN	0
may	may	MD	0
represent	represent	VB	0
a	a	DT	0
particularly	particularly	RB	0
fertile	fertile	JJ	0
area	area	NN	0
for	for	IN	0
research	research	NN	0
.	.	.	0
Any	Any	DT	0
combination	combination	NN	0
of	of	IN	0
such	such	JJ	0
steps	steps	NNS	0
may	may	MD	0
significantly	significantly	RB	0
alter	alter	VB	0
the	the	DT	0
molecular	molecular	JJ	B-NP
subset	subset	NN	I-NP
of	of	IN	0
the	the	DT	0
sample	sample	NN	0
that	that	WDT	0
can	can	MD	0
be	be	VB	0
successfully	successfully	RB	0
analyzed	analyzed	VBD	0
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
ability	ability	NN	B-NP
to	to	TO	0
discriminate	discriminate	VB	0
between	between	IN	0
cancer	cancer	NN	0
and	and	CC	0
control	control	VB	0
based	based	VBN	0
on	on	IN	0
the	the	DT	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
of	of	IN	0
2.79	2.79	CD	0
and	and	CC	0
245.5	245.5	NNP	0
reveals	reveals	VBZ	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
a	a	DT	0
significant	significant	JJ	0
experimental	experimental	JJ	B-NP
bias	bias	NN	I-NP
not	not	RB	0
related	related	VBN	0
to	to	TO	0
disease	disease	NN	B-NP
pathology	pathology	NN	I-NP
,	,	,	0
that	that	WDT	0
likely	likely	RB	0
involves	involves	VBZ	0
machine	machine	NN	B-NP
noise	noise	NN	I-NP
and	and	CC	0
matrix	matrix	JJ	B-NP
effect	effect	NN	I-NP
.	.	.	0
This	This	DT	0
is	is	VBZ	0
particularly	particularly	RB	0
true	true	JJ	0
of	of	IN	0
the	the	DT	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
value	value	NN	I-NP
at	at	IN	0
2.79	2.79	CD	0
which	which	WDT	0
represents	represents	VBZ	0
a	a	DT	0
bias	bias	NN	0
of	of	IN	0
the	the	DT	0
mass	mass	JJ	0
spectrometer	spectrometer	JJ	B-NP
instrument	instrument	NN	I-NP
itself	itself	PRP	0
.	.	.	0
If	If	IN	0
this	this	DT	0
is	is	VBZ	0
the	the	DT	0
case	case	NN	0
the	the	DT	0
higher	higher	JJR	0
m/z	m/z	NN	B-NP
region	region	NN	I-NP
may	may	MD	0
also	also	RB	0
be	be	VB	0
affected	affected	VBN	0
.	.	.	0
These	These	DT	0
findings	findings	NNS	0
indicate	indicate	VBP	0
that	that	IN	0
any	any	DT	0
rule	rule	NN	0
derived	derived	VBN	0
from	from	IN	0
this	this	DT	0
data	data	NNS	0
set	set	VBN	0
,	,	,	0
including	including	VBG	0
the	the	DT	0
one	one	CD	B-NP
presented	presented	VBN	0
in	in	IN	0
this	this	DT	0
paper	paper	NN	0
,	,	,	0
may	may	MD	0
be	be	VB	0
detecting	detecting	JJ	0
differences	differences	NNS	0
in	in	IN	0
experimental	experimental	JJ	B-NP
bias	bias	NN	I-NP
and	and	CC	0
not	not	RB	0
disease	disease	JJ	B-NP
pathology	pathology	NN	I-NP
.	.	.	0
investigator	investigator	NN	B-NP
in	in	IN	0
this	this	DT	0
field	field	NN	0
may	may	MD	0
minimize	minimize	VB	0
their	their	PRP$	0
chances	chances	NNS	0
of	of	IN	0
false	false	JJ	0
discovery	discovery	NN	0
by	by	IN	0
careful	careful	JJ	0
experimental	experimental	JJ	0
design	design	NN	0
and	and	CC	0
by	by	IN	0
using	using	VBG	0
routine	routine	JJ	B-NP
statistical	statistical	JJ	I-NP
method	method	NN	I-NP
to	to	TO	0
both	both	DT	0
overview	overview	NN	B-NP
the	the	DT	0
data	data	NNS	0
(	(	-LRB-	0
in	in	IN	0
an	an	DT	0
intentional	intentional	JJ	B-NP
search	search	NN	I-NP
for	for	IN	0
bias	bias	NN	0
)	)	-RRB-	0
as	as	IN	0
well	well	RB	0
as	as	IN	0
a	a	DT	0
benchmark	benchmark	NN	0
for	for	IN	0
comparison	comparison	NN	0
with	with	IN	0
other	other	JJ	0
data	data	NN	B-NP
mining	mining	NN	I-NP
algorithm	algorithm	NN	I-NP
.	.	.	0
Methods	Methods	NNS	0
A	A	DT	0
training	training	NN	B-NP
set	set	NN	I-NP
was	was	VBD	0
formed	formed	VBN	0
by	by	IN	0
randomly	randomly	RB	0
sampling	sampling	CD	0
45	45	CD	0
spectra	spectra	NNS	0
out	out	RP	0
of	of	IN	0
the	the	DT	0
91	91	CD	0
controls	controls	NNS	0
and	and	CC	0
80	80	CD	0
spectra	spectra	NNS	0
out	out	RP	0
of	of	IN	0
the	the	DT	0
162	162	CD	0
cancer	cancer	NN	B-NP
case	case	NN	I-NP
(	(	-LRB-	0
see	see	VB	0
Figure	Figure	NNP	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
Those	Those	DT	0
spectra	spectra	NN	0
that	that	WDT	0
were	were	VBD	0
in	in	IN	0
the	the	DT	0
original	original	JJ	B-NP
data	data	NN	I-NP
set	set	VBN	0
but	but	CC	0
not	not	RB	0
in	in	IN	0
the	the	DT	0
training	training	NN	B-NP
set	set	NN	I-NP
were	were	VBD	0
considered	considered	VBN	0
in	in	IN	0
a	a	DT	0
'	'	POS	0
test	test	NN	0
'	'	POS	0
set	set	NN	0
.	.	.	0
Two-sided	Two-sided	NNP	0
Wilcoxon	Wilcoxon	NNP	B-NP
test	test	NN	I-NP
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
compare	compare	VB	0
the	the	DT	0
intensity	intensity	NN	0
between	between	IN	0
the	the	DT	0
controls	controls	NNS	0
and	and	CC	0
cancers	cancers	NNS	0
in	in	IN	0
the	the	DT	0
training	training	NN	0
set	set	VBN	0
at	at	IN	0
each	each	DT	0
of	of	IN	0
the	the	DT	0
15,154	15,154	NNP	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
.	.	.	0
We	We	PRP	0
then	then	RB	0
selected	selected	VBN	0
a	a	DT	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
subset	subset	NN	I-NP
with	with	IN	0
the	the	DT	0
lowest	lowest	JJS	0
wilcoxon	wilcoxon	NNP	B-NP
test	test	NN	I-NP
p-value	p-value	NN	I-NP
(	(	-LRB-	0
see	see	VB	0
the	the	DT	0
Results	Results	NNS	0
section	section	NN	0
for	for	IN	0
details	details	NNS	0
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
sorted	sorted	VBD	0
on	on	IN	0
consecutive	consecutive	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
values	values	VBZ	0
to	to	TO	0
get	get	VB	0
bins	bins	NNS	0
.	.	.	0
A	A	DT	0
separation	separation	NN	0
of	of	IN	0
at	at	IN	0
least	least	JJS	0
one	one	CD	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
value	value	NN	I-NP
was	was	VBD	0
required	required	VBN	0
to	to	TO	0
start	start	VB	0
the	the	DT	0
next	next	JJ	0
bin	bin	NN	0
.	.	.	0
The	The	DT	0
lowest	lowest	JJS	0
p-value	p-value	JJ	B-NP
in	in	IN	0
each	each	DT	0
bin	bin	NN	0
was	was	VBD	0
selected	selected	VBN	0
and	and	CC	0
the	the	DT	0
corresponding	corresponding	JJ	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
value	value	NN	I-NP
was	was	VBD	0
used	used	VBN	0
in	in	IN	0
stepwise	stepwise	JJ	B-NP
discriminant	discriminant	JJ	I-NP
analysis	analysis	NN	I-NP
to	to	TO	0
determine	determine	VB	0
the	the	DT	0
m/z	m/z	NN	B-NP
value	value	NN	I-NP
subset	subset	NN	I-NP
that	that	IN	0
best	best	JJS	0
discriminated	discriminated	JJ	0
cancer	cancer	NN	0
from	from	IN	0
control	control	NN	0
in	in	IN	0
the	the	DT	0
training	training	NN	B-NP
set	set	NN	I-NP
.	.	.	0
The	The	DT	0
criteria	criteria	NNS	0
were	were	VBD	0
applied	applied	VBN	0
to	to	TO	0
the	the	DT	0
test	test	NN	B-NP
data	data	NN	I-NP
set	set	VBN	0
,	,	,	0
and	and	CC	0
sensitivity	sensitivity	NN	0
and	and	CC	0
specificity	specificity	NN	0
were	were	VBD	0
computed	computed	VBN	0
.	.	.	0
All	All	PDT	0
the	the	DT	0
analyses	analyses	NNS	0
were	were	VBD	0
performed	performed	VBN	0
in	in	IN	0
SAS	SAS	NNP	B-NP
Version	Version	NNP	I-NP
8.2	8.2	CD	0
(	(	-LRB-	0
A	A	DT	0
statistical	statistical	JJ	B-NP
package	package	NN	I-NP
from	from	IN	0
SAS	SAS	NNP	0
Institute	Institute	NNP	0
Inc.	Inc.	NNP	0
,	,	,	0
Cary	Cary	NNP	0
,	,	,	0
no	no	DT	B-NP
change	change	NN	I-NP
,	,	,	0
USA	USA	NNP	B-NP
)	)	-RRB-	0
on	on	IN	0
a	a	DT	0
personal	personal	JJ	B-NP
computer	computer	NN	I-NP
.	.	.	0
Wilcoxon	Wilcoxon	JJ	B-NP
test	test	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
NPAR1WAY	NPAR1WAY	CD	0
procedure	procedure	NN	0
in	in	IN	0
sa	sa	NN	B-NP
,	,	,	0
stepwise	stepwise	JJ	B-NP
discriminant	discriminant	JJ	I-NP
analysis	analysis	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
STEPDISC	STEPDISC	NNP	B-NP
procedure	procedure	NN	I-NP
in	in	IN	0
sa	sa	NN	B-NP
,	,	,	0
and	and	CC	0
discriminant	discriminant	JJ	B-NP
analysis	analysis	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
DISCRIM	DISCRIM	NNP	B-NP
procedure	procedure	NN	I-NP
in	in	IN	0
sa	sa	NN	B-NP
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
normalize	normalize	VB	0
the	the	DT	0
data	data	NNS	0
,	,	,	0
the	the	DT	0
procedure	procedure	NN	0
outlined	outlined	VBN	0
by	by	IN	0
the	the	DT	0
Clinical	Clinical	NNP	B-NP
Proteomics	Proteomics	NNP	I-NP
Program	Program	NNP	I-NP
Databank	Databank	NNP	I-NP
was	was	VBD	0
used	used	VBN	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
cancer	cancer	NN	0
and	and	CC	0
control	control	NN	B-NP
value	value	NN	I-NP
for	for	IN	0
each	each	DT	0
M	M	NNP	B-NP
/	/	NNP	I-NP
Z	Z	NNP	I-NP
were	were	VBD	0
given	given	VBN	0
respective	respective	JJ	0
labels	labels	NNS	0
,	,	,	0
and	and	CC	0
the	the	DT	0
data	data	NNS	0
were	were	VBD	0
then	then	RB	0
pooled	pooled	VBN	0
and	and	CC	0
normalized	normalized	VBP	0
using	using	VBG	0
the	the	DT	0
formula	formula	NN	B-NP
NV	NV	NNP	I-NP
=	=	NNP	0
(	(	-LRB-	0
V-Min	V-Min	NNP	B-NP
)	)	-RRB-	0
/	/	NNP	0
(	(	-LRB-	0
Max	Max	NNP	0
-	-	:	0
Min	Min	LS	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
this	this	DT	0
expression	expression	NN	0
,	,	,	0
Min	Min	NNP	0
is	is	VBZ	0
the	the	DT	0
minimum	minimum	JJ	0
intensity	intensity	NN	0
of	of	IN	0
the	the	DT	0
pooled	pooled	JJ	0
samples	samples	NNS	0
,	,	,	0
Max	Max	NNP	0
represents	represents	VBZ	0
the	the	DT	0
maximum	maximum	JJ	0
intensity	intensity	NN	0
found	found	VBD	0
in	in	IN	0
the	the	DT	0
pooled	pooled	JJ	0
samples	samples	NNS	0
,	,	,	0
and	and	CC	0
NV	NV	NNP	B-NP
represents	represents	VBZ	0
the	the	DT	0
normalized	normalized	JJ	0
value	value	NN	0
.	.	.	0
Using	Using	VBG	0
this	this	DT	0
procedure	procedure	NN	0
,	,	,	0
the	the	DT	0
data	data	NN	0
intensities	intensities	NNS	0
will	will	MD	0
all	all	RB	0
fall	fall	VB	0
between	between	IN	0
0	0	CD	0
and	and	CC	0
1	1	CD	0
.	.	.	0
The	The	DT	0
data	data	NN	0
points	points	NNS	0
were	were	VBD	0
sorted	sorted	VBN	0
into	into	IN	0
cancer	cancer	NN	0
and	and	CC	0
controls	controls	NNS	0
,	,	,	0
and	and	CC	0
the	the	DT	0
p-value	p-value	NN	B-NP
were	were	VBD	0
calculated	calculated	VBN	0
.	.	.	0
Authors	Authors	NNP	0
'	'	POS	0
contribution	contribution	NN	B-NP
JMS	JMS	VBP	0
conceived	conceived	VBN	0
of	of	IN	0
the	the	DT	0
studies	studies	NNS	0
and	and	CC	0
developed	developed	VBD	0
the	the	DT	0
initial	initial	JJ	0
process	process	NN	0
for	for	IN	0
selecting	selecting	VBG	0
diagnostic	diagnostic	JJ	B-NP
rule	rule	NN	I-NP
.	.	.	0
MZ	MZ	NNP	B-NP
performed	performed	VBD	0
the	the	DT	0
statistical	statistical	JJ	B-NP
analysis	analysis	NN	I-NP
and	and	CC	0
further	further	RB	0
refined	refined	VBN	0
the	the	DT	0
rules	rules	NNS	0
with	with	IN	0
stepwise	stepwise	JJ	B-NP
discrminant	discrminant	JJ	I-NP
analysis	analysis	NN	I-NP
.	.	.	0
All	All	DT	0
authors	authors	NNS	0
read	read	VBP	0
and	and	CC	0
agreed	agreed	VBD	0
with	with	IN	0
the	the	DT	0
final	final	JJ	B-NP
manuscript	manuscript	NN	I-NP
.	.	.	0
